The	O
surface	O
ectoderm	O
is	O
essential	O
for	O
nephric	O
duct	O
formation	O
in	O
intermediate	O
mesoderm	O
.	O

The	O
nephric	O
duct	O
is	O
the	O
first	O
epithelial	O
tubule	O
to	O
differentiate	O
from	O
intermediate	O
mesoderm	O
that	O
is	O
essential	O
for	O
all	O
further	O
urogenital	O
development	O
.	O

In	O
this	O
study	O
we	O
identify	O
the	O
domain	O
of	O
intermediate	O
mesoderm	O
that	O
gives	O
rise	O
to	O
the	O
nephric	O
duct	O
and	O
demonstrate	O
that	O
the	O
surface	O
ectoderm	O
is	O
required	O
for	O
its	O
differentiation	O
.	O

Removal	O
of	O
the	O
surface	O
ectoderm	O
resulted	O
in	O
decreased	O
levels	O
of	O
Sim	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
Pax	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
mRNA	O
expression	O
in	O
mesenchymal	O
nephric	O
duct	O
progenitors	O
,	O
and	O
caused	O
inhibition	O
of	O
nephric	O
duct	O
formation	O
and	O
subsequent	O
kidney	O
development	O
.	O

The	O
surface	O
ectoderm	O
expresses	O
BMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
and	O
we	O
show	O
that	O
it	O
is	O
required	O
for	O
the	O
maintenance	O
of	O
high	O
-	O
level	O
BMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
expression	O
in	O
lateral	O
plate	O
mesoderm	O
.	O

Addition	O
of	O
a	O
BMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
-	O
coated	O
bead	O
to	O
embryos	O
lacking	O
the	O
surface	O
ectoderm	O
restored	O
normal	O
levels	O
of	O
Sim	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
Pax	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
mRNA	O
expression	O
in	O
nephric	O
duct	O
progenitors	O
,	O
nephric	O
duct	O
formation	O
and	O
the	O
initiation	O
of	O
nephrogenesis	O
.	O

Thus	O
,	O
BMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
signaling	O
can	O
substitute	O
for	O
the	O
surface	O
ectoderm	O
in	O
supporting	O
nephric	O
duct	O
morphogenesis	O
.	O

Collectively	O
,	O
these	O
data	O
suggest	O
that	O
inductive	O
interactions	O
between	O
the	O
surface	O
ectoderm	O
,	O
lateral	O
mesoderm	O
and	O
intermediate	O
mesoderm	O
are	O
essential	O
for	O
nephric	O
duct	O
formation	O
and	O
the	O
initiation	O
of	O
urogenital	O
development	O
.	O

Identification	O
of	O
APC2	B-Gene_or_gene_product
,	O
a	O
homologue	O
of	O
the	O
adenomatous	B-Gene_or_gene_product
polyposis	I-Gene_or_gene_product
coli	I-Gene_or_gene_product
tumour	I-Gene_or_gene_product
suppressor	I-Gene_or_gene_product
.	O

The	O
adenomatous	B-Gene_or_gene_product
polyposis	I-Gene_or_gene_product
coli	I-Gene_or_gene_product
(	I-Gene_or_gene_product
APC	I-Gene_or_gene_product
)	I-Gene_or_gene_product
tumour	I-Gene_or_gene_product
-	I-Gene_or_gene_product
suppressor	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
controls	O
the	O
Wnt	B-Gene_or_gene_product
signalling	O
pathway	O
by	O
forming	O
a	O
complex	O
with	O
glycogen	O
synthase	O
kinase	O
3beta	O
(	O
GSK	O
-	O
3beta	O
)	O
,	O
axin	B-Gene_or_gene_product
/	I-Gene_or_gene_product
conductin	I-Gene_or_gene_product
and	O
betacatenin	B-Gene_or_gene_product
.	O

Complex	O
formation	O
induces	O
the	O
rapid	O
degradation	O
of	O
betacatenin	B-Gene_or_gene_product
.	O

In	O
colon	O
carcinoma	O
cells	O
,	O
loss	O
of	O
APC	B-Gene_or_gene_product
leads	O
to	O
the	O
accumulation	O
of	O
betacatenin	B-Gene_or_gene_product
in	O
the	O
nucleus	O
,	O
where	O
it	O
binds	O
to	O
and	O
activates	O
the	O
Tcf	O
-	O
4	O
transcription	O
factor	O
(	O
reviewed	O
in	O
[	O
1	O
]	O
[	O
2	O
]	O
)	O
.	O

Here	O
,	O
we	O
report	O
the	O
identification	O
and	O
genomic	O
structure	O
of	O
APC	B-Gene_or_gene_product
homologues	O
.	O

Mammalian	O
APC2	B-Gene_or_gene_product
,	O
which	O
closely	O
resembles	O
APC	B-Gene_or_gene_product
in	O
overall	O
domain	O
structure	O
,	O
was	O
functionally	O
analyzed	O
and	O
shown	O
to	O
contain	O
two	O
SAMP	O
domains	O
,	O
both	O
of	O
which	O
are	O
required	O
for	O
binding	O
to	O
conductin	B-Gene_or_gene_product
.	O

Like	O
APC	B-Gene_or_gene_product
,	O
APC2	B-Gene_or_gene_product
regulates	O
the	O
formation	O
of	O
active	O
betacatenin	B-Gene_or_gene_product
-	O
Tcf	B-Gene_or_gene_product
complexes	O
,	O
as	O
demonstrated	O
using	O
transient	O
transcriptional	O
activation	O
assays	O
in	O
APC	B-Gene_or_gene_product
-	O
/	O
-	O
colon	O
carcinoma	O
cells	O
.	O

Human	O
APC2	B-Gene_or_gene_product
maps	O
to	O
chromosome	O
19p13	O
.	O
3	O
.	O

APC	B-Gene_or_gene_product
and	O
APC2	B-Gene_or_gene_product
may	O
therefore	O
have	O
comparable	O
functions	O
in	O
development	O
and	O
cancer	O
.	O

TIF1gamma	O
,	O
a	O
novel	O
member	O
of	O
the	O
transcriptional	O
intermediary	O
factor	O
1	O
family	O
.	O

We	O
report	O
the	O
cloning	O
and	O
characterization	O
of	O
a	O
novel	O
member	O
of	O
the	O
Transcriptional	O
Intermediary	O
Factor	O
1	O
(	O
TIF1	O
)	O
gene	B-Gene_or_gene_product
family	I-Gene_or_gene_product
,	O
human	O
TIF1gamma	O
.	O

Similar	O
to	O
TIF1alpha	O
and	O
TIF1beta	O
,	O
the	O
structure	O
of	O
TIF1beta	O
is	O
characterized	O
by	O
multiple	O
domains	O
:	O
RING	O
finger	O
,	O
B	O
boxes	O
,	O
Coiled	O
coil	O
,	O
PHD	O
/	O
TTC	O
,	O
and	O
bromodomain	O
.	O

Although	O
structurally	O
related	O
to	O
TIF1alpha	O
and	O
TIF1beta	O
,	O
TIF1gamma	O
presents	O
several	O
functional	O
differences	O
.	O

In	O
contrast	O
to	O
TIF1alpha	O
,	O
but	O
like	O
TIF1beta	O
,	O
TIF1	O
does	O
not	O
interact	O
with	O
nuclear	O
receptors	O
in	O
yeast	O
two	O
-	O
hybrid	O
or	O
GST	O
pull	O
-	O
down	O
assays	O
and	O
does	O
not	O
interfere	O
with	O
retinoic	O
acid	O
response	O
in	O
transfected	O
mammalian	O
cells	O
.	O

Whereas	O
TIF1alpha	O
and	O
TIF1beta	O
were	O
previously	O
found	O
to	O
interact	O
with	O
the	O
KRAB	O
silencing	O
domain	O
of	O
KOX1	O
and	O
with	O
the	O
HP1alpha	O
,	O
MODI	O
(	O
HP1beta	O
)	O
and	O
MOD2	O
(	O
HP1gamma	O
)	O
heterochromatinic	O
proteins	B-Gene_or_gene_product
,	O
suggesting	O
that	O
they	O
may	O
participate	O
in	O
a	O
complex	O
involved	O
in	O
heterochromatin	O
-	O
induced	O
gene	O
repression	O
,	O
TIF1gamma	O
does	O
not	O
interact	O
with	O
either	O
the	O
KRAB	O
domain	O
of	O
KOX1	O
or	O
the	O
HP1	O
proteins	O
.	O

Nevertheless	O
,	O
TIF1gamma	O
,	O
like	O
TIF1alpha	O
and	O
TIF1beta	O
,	O
exhibits	O
a	O
strong	O
silencing	O
activity	O
when	O
tethered	O
to	O
a	O
promoter	O
.	O

Since	O
deletion	O
of	O
a	O
novel	O
motif	O
unique	O
to	O
the	O
three	O
TIF1	O
proteins	O
,	O
called	O
TIF1	O
signature	O
sequence	O
(	O
TSS	O
)	O
,	O
abrogates	O
transcriptional	O
repression	O
by	O
TIF1gamma	O
,	O
this	O
motif	O
likely	O
participates	O
in	O
TIF1	O
dependent	O
repression	O
.	O

Role	O
of	O
alphavbeta3	B-Gene_or_gene_product
integrin	I-Gene_or_gene_product
in	O
the	O
activation	O
of	O
vascular	B-Gene_or_gene_product
endothelial	I-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
.	O

Interaction	O
between	O
integrin	B-Gene_or_gene_product
alphavbeta3	I-Gene_or_gene_product
and	O
extracellular	O
matrix	O
is	O
crucial	O
for	O
endothelial	O
cells	O
sprouting	O
from	O
capillaries	O
and	O
for	O
angiogenesis	O
.	O

Furthermore	O
,	O
integrin	B-Gene_or_gene_product
-	O
mediated	O
outside	O
-	O
in	O
signals	O
co	O
-	O
operate	O
with	O
growth	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
to	O
promote	O
cell	O
proliferation	O
and	O
motility	O
.	O

To	O
determine	O
a	O
potential	O
regulation	O
of	O
angiogenic	B-Gene_or_gene_product
inducer	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
by	O
the	O
integrin	B-Gene_or_gene_product
system	O
,	O
we	O
investigated	O
the	O
interaction	O
between	O
alphavbeta3	B-Gene_or_gene_product
integrin	I-Gene_or_gene_product
and	O
tyrosine	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
vascular	I-Gene_or_gene_product
endothelial	I-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
(	O
VEGFR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
)	O
in	O
human	O
endothelial	O
cells	O
.	O

We	O
report	O
that	O
tyrosine	O
-	O
phosphorylated	O
VEGFR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
co	O
-	O
immunoprecipitated	O
with	O
beta3	O
integrin	O
subunit	O
,	O
but	O
not	O
with	O
beta1	O
or	O
beta5	O
,	O
from	O
cells	O
stimulated	O
with	O
VEGF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
A165	I-Gene_or_gene_product
.	O

VEGFR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
phosphorylation	O
and	O
mitogenicity	O
induced	O
by	O
VEGF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
A165	I-Gene_or_gene_product
were	O
enhanced	O
in	O
cells	O
plated	O
on	O
the	O
alphavbeta3	B-Gene_or_gene_product
ligand	O
,	O
vitronectin	B-Gene_or_gene_product
,	O
compared	O
with	O
cells	O
plated	O
on	O
the	O
alpha5beta1	B-Gene_or_gene_product
ligand	O
,	O
fibronectin	B-Gene_or_gene_product
or	O
the	O
alpha2beta1	B-Gene_or_gene_product
ligand	O
,	O
collagen	B-Gene_or_gene_product
.	O

BV4	B-Gene_or_gene_product
anti	I-Gene_or_gene_product
-	I-Gene_or_gene_product
beta3	I-Gene_or_gene_product
integrin	I-Gene_or_gene_product
mAb	I-Gene_or_gene_product
,	O
which	O
does	O
not	O
interfere	O
with	O
endothelial	O
cell	O
adhesion	O
to	O
vitronectin	B-Gene_or_gene_product
,	O
reduced	O
(	O
i	O
)	O
the	O
tyrosine	O
phosphorylation	O
of	O
VEGFR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
;	O
(	O
ii	O
)	O
the	O
activation	O
of	O
downstream	O
transductor	O
phosphoinositide	O
3	O
-	O
OH	O
kinase	O
;	O
and	O
(	O
iii	O
)	O
biological	O
effects	O
triggered	O
by	O
VEGF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
A165	I-Gene_or_gene_product
.	O

These	O
results	O
indicate	O
a	O
new	O
role	O
for	O
alphavbeta3	B-Gene_or_gene_product
integrin	I-Gene_or_gene_product
in	O
the	O
activation	O
of	O
an	O
in	O
vitro	O
angiogenic	O
program	O
in	O
endothelial	O
cells	O
.	O

Besides	O
being	O
the	O
most	O
important	O
survival	O
system	O
for	O
nascent	O
vessels	O
by	O
regulating	O
cell	O
adhesion	O
to	O
matrix	O
,	O
alphavbeta3	B-Gene_or_gene_product
integrin	I-Gene_or_gene_product
participates	O
in	O
the	O
full	O
activation	O
of	O
VEGFR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
triggered	O
by	O
VEGF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
A	I-Gene_or_gene_product
,	O
which	O
is	O
an	O
important	O
angiogenic	O
inducer	O
in	O
tumors	O
,	O
inflammation	O
and	O
tissue	O
regeneration	O
.	O

A	O
novel	O
genetic	O
screen	O
for	O
snRNP	B-Gene_or_gene_product
assembly	I-Gene_or_gene_product
factors	I-Gene_or_gene_product
in	O
yeast	O
identifies	O
a	O
conserved	O
protein	O
,	O
Sad1p	B-Gene_or_gene_product
,	O
also	O
required	O
for	O
pre	O
-	O
mRNA	O
splicing	O
.	O

The	O
assembly	O
pathway	O
of	O
spliceosomal	O
snRNPs	O
in	O
yeast	O
is	O
poorly	O
understood	O
.	O

We	O
devised	O
a	O
screen	O
to	O
identify	O
mutations	O
blocking	O
the	O
assembly	O
of	O
newly	O
synthesized	O
U4	O
snRNA	O
into	O
a	O
functional	O
snRNP	O
.	O

Fifteen	O
mutant	O
strains	O
failing	O
either	O
to	O
accumulate	O
the	O
newly	O
synthesized	O
U4	O
snRNA	O
or	O
to	O
assemble	O
a	O
U4	O
/	O
U6	O
particle	O
were	O
identified	O
and	O
categorized	O
into	O
13	O
complementation	O
groups	O
.	O

Thirteen	O
previously	O
identified	O
splicing	O
-	O
defective	O
prp	B-Gene_or_gene_product
mutants	O
were	O
also	O
assayed	O
for	O
U4	O
snRNP	O
assembly	O
defects	O
.	O

Mutations	O
in	O
the	O
U4	O
/	O
U6	O
snRNP	O
components	O
Prp3p	B-Gene_or_gene_product
,	O
Prp4p	B-Gene_or_gene_product
,	O
and	O
Prp24p	B-Gene_or_gene_product
led	O
to	O
disassembly	O
of	O
the	O
U4	O
/	O
U6	O
snRNP	O
particle	O
and	O
degradation	O
of	O
the	O
U6	O
snRNA	O
,	O
while	O
prp17	O
-	O
1	O
and	O
prp19	O
-	O
1	O
strains	O
accumulated	O
free	O
U4	O
and	O
U6	O
snRNA	O
.	O

A	O
detailed	O
analysis	O
of	O
a	O
newly	O
identified	O
mutant	O
,	O
the	O
sad1	O
-	O
1	O
mutant	O
,	O
is	O
presented	O
.	O

In	O
addition	O
to	O
having	O
the	O
snRNP	O
assembly	O
defect	O
,	O
the	O
sad1	O
-	O
1	O
mutant	O
is	O
severely	O
impaired	O
in	O
splicing	O
at	O
the	O
restrictive	O
temperature	O
:	O
the	O
RP29	O
pre	O
-	O
mRNA	O
strongly	O
accumulates	O
and	O
splicing	O
-	O
dependent	O
production	O
of	O
beta	O
-	O
galactosidase	O
from	O
reporter	O
constructs	O
is	O
abolished	O
,	O
while	O
extracts	O
prepared	O
from	O
sad1	O
-	O
1	O
strains	O
fail	O
to	O
splice	O
pre	O
-	O
mRNA	O
substrates	O
in	O
vitro	O
.	O

The	O
sad1	O
-	O
1	O
mutant	O
is	O
the	O
only	O
splicing	O
-	O
defective	O
mutant	O
analyzed	O
whose	O
mutation	O
preferentially	O
affects	O
assembly	O
of	O
newly	O
synthesized	O
U4	O
snRNA	O
into	O
the	O
U4	O
/	O
U6	O
particle	O
.	O

SAD1	O
encodes	O
a	O
novel	O
protein	O
of	O
52	O
kDa	O
which	O
is	O
essential	O
for	O
cell	O
viability	O
.	O

Sad1p	B-Gene_or_gene_product
localizes	O
to	O
the	O
nucleus	O
and	O
is	O
not	O
stably	O
associated	O
with	O
any	O
of	O
the	O
U	O
snRNAs	O
.	O

Sad1p	B-Gene_or_gene_product
contains	O
a	O
putative	O
zinc	O
finger	O
and	O
is	O
phylogenetically	O
highly	O
conserved	O
,	O
with	O
homologues	O
identified	O
in	O
human	O
,	O
Caenorhabditis	O
elegans	O
,	O
Arabidospis	O
,	O
and	O
Drosophila	O
.	O

Activation	O
of	O
IkappaB	O
kinase	O
beta	O
by	O
protein	O
kinase	O
C	O
isoforms	O
.	O

The	O
atypical	O
protein	O
kinase	O
C	O
(	O
PKC	O
)	O
isotypes	O
(	O
lambda	O
/	O
iotaPKC	O
and	O
zetaPKC	O
)	O
have	O
been	O
shown	O
to	O
be	O
critically	O
involved	O
in	O
important	O
cell	O
functions	O
such	O
as	O
proliferation	O
and	O
survival	O
.	O

Previous	O
studies	O
have	O
demonstrated	O
that	O
the	O
atypical	O
PKCs	O
are	O
stimulated	O
by	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
(	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
)	O
and	O
are	O
required	O
for	O
the	O
activation	O
of	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
by	O
this	O
cytokine	B-Gene_or_gene_product
through	O
a	O
mechanism	O
that	O
most	O
probably	O
involves	O
the	O
phosphorylation	O
of	O
IkappaB	B-Gene_or_gene_product
.	O

The	O
inability	O
of	O
these	O
PKC	O
isotypes	O
to	O
directly	O
phosphorylate	O
IkappaB	B-Gene_or_gene_product
led	O
to	O
the	O
hypothesis	O
that	O
zetaPKC	O
may	O
use	O
a	O
putative	O
IkappaB	O
kinase	O
to	O
functionally	O
inactivate	O
IkappaB	B-Gene_or_gene_product
.	O

Recently	O
several	O
groups	O
have	O
molecularly	O
characterized	O
and	O
cloned	O
two	O
IkappaB	O
kinases	O
(	O
IKKalpha	O
and	O
IKKbeta	O
)	O
which	O
phosphorylate	O
the	O
residues	O
in	O
the	O
IkappaB	B-Gene_or_gene_product
molecule	I-Gene_or_gene_product
that	O
serve	O
to	O
target	O
it	O
for	O
ubiquitination	O
and	O
degradation	O
.	O

In	O
this	O
study	O
we	O
have	O
addressed	O
the	O
possibility	O
that	O
different	O
PKCs	O
may	O
control	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
through	O
the	O
activation	O
of	O
the	O
IKKs	O
.	O

We	O
report	O
here	O
that	O
alphaPKC	O
as	O
well	O
as	O
the	O
atypical	O
PKCs	O
bind	O
to	O
the	O
IKKs	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

In	O
addition	O
,	O
overexpression	O
of	O
zetaPKC	O
positively	O
modulates	O
IKKbeta	O
activity	O
but	O
not	O
that	O
of	O
IKKalpha	O
,	O
whereas	O
the	O
transfection	O
of	O
a	O
zetaPKC	O
dominant	O
negative	O
mutant	O
severely	O
impairs	O
the	O
activation	O
of	O
IKKbeta	O
but	O
not	O
IKKalpha	O
in	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	O
stimulated	O
cells	O
.	O

We	O
also	O
show	O
that	O
cell	O
stimulation	O
with	O
phorbol	O
12	O
-	O
myristate	O
13	O
-	O
acetate	O
activates	O
IKKbeta	O
,	O
which	O
is	O
entirely	O
dependent	O
on	O
the	O
activity	O
of	O
alphaPKC	O
but	O
not	O
that	O
of	O
the	O
atypical	O
isoforms	O
.	O

In	O
contrast	O
,	O
the	O
inhibition	O
of	O
alphaPKC	O
does	O
not	O
affect	O
the	O
activation	O
of	O
IKKbeta	O
by	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
.	O

Interestingly	O
,	O
recombinant	O
active	O
zetaPKC	O
and	O
alphaPKC	O
are	O
able	O
to	O
stimulate	O
in	O
vitro	O
the	O
activity	O
of	O
IKKbeta	O
but	O
not	O
that	O
of	O
IKKalpha	O
.	O

In	O
addition	O
,	O
evidence	O
is	O
presented	O
here	O
that	O
recombinant	O
zetaPKC	O
directly	O
phosphorylates	O
IKKbeta	O
in	O
vitro	O
,	O
involving	O
Ser177	O
and	O
Ser181	O
.	O

Collectively	O
,	O
these	O
results	O
demonstrate	O
a	O
critical	O
role	O
for	O
the	O
PKC	O
isoforms	O
in	O
the	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
pathway	O
at	O
the	O
level	O
of	O
IKKbeta	O
activation	O
and	O
IkappaB	B-Gene_or_gene_product
degradation	O
.	O

Mammalian	O
staufen	B-Gene_or_gene_product
is	O
a	O
double	O
-	O
stranded	O
-	O
RNA	O
-	O
and	O
tubulin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
which	O
localizes	O
to	O
the	O
rough	O
endoplasmic	O
reticulum	O
.	O

Staufen	B-Gene_or_gene_product
(	O
Stau	B-Gene_or_gene_product
)	O
is	O
a	O
double	O
-	O
stranded	O
RNA	O
(	O
dsRNA	O
)	O
-	O
binding	O
protein	B-Gene_or_gene_product
involved	O
in	O
mRNA	O
transport	O
and	O
localization	O
in	O
Drosophila	O
.	O

To	O
understand	O
the	O
molecular	O
mechanisms	O
of	O
mRNA	O
transport	O
in	O
mammals	O
,	O
we	O
cloned	O
human	O
(	O
hStau	B-Gene_or_gene_product
)	O
and	O
mouse	O
(	O
mStau	B-Gene_or_gene_product
)	O
staufen	B-Gene_or_gene_product
cDNAs	O
.	O

In	O
humans	O
,	O
four	O
transcripts	O
arise	O
by	O
differential	O
splicing	O
of	O
the	O
Stau	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
and	O
code	O
for	O
two	O
proteins	B-Gene_or_gene_product
with	O
different	O
N	O
-	O
terminal	O
extremities	O
.	O

In	O
vitro	O
,	O
hStau	B-Gene_or_gene_product
and	O
mStau	B-Gene_or_gene_product
bind	O
dsRNA	O
via	O
each	O
of	O
two	O
full	O
-	O
length	O
dsRNA	O
-	O
binding	O
domains	O
and	O
tubulin	B-Gene_or_gene_product
via	O
a	O
region	O
similar	O
to	O
the	O
microtubule	O
-	O
binding	O
domain	O
of	O
MAP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1B	I-Gene_or_gene_product
,	O
suggesting	O
that	O
Stau	B-Gene_or_gene_product
cross	O
-	O
links	O
cytoskeletal	O
and	O
RNA	O
components	O
.	O

Immunofluorescent	O
double	O
labeling	O
of	O
transfected	O
mammalian	O
cells	O
revealed	O
that	O
Stau	B-Gene_or_gene_product
is	O
localized	O
to	O
the	O
rough	O
endoplasmic	O
reticulum	O
(	O
RER	O
)	O
,	O
implicating	O
this	O
RNA	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
in	O
mRNA	O
targeting	O
to	O
the	O
RER	O
,	O
perhaps	O
via	O
a	O
multistep	O
process	O
involving	O
microtubules	O
.	O

These	O
results	O
are	O
the	O
first	O
demonstration	O
of	O
the	O
association	O
of	O
an	O
RNA	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
in	O
addition	O
to	O
ribosomal	O
proteins	B-Gene_or_gene_product
,	O
with	O
the	O
RER	O
,	O
implicating	O
this	O
class	O
of	O
proteins	B-Gene_or_gene_product
in	O
the	O
transport	O
of	O
RNA	O
to	O
its	O
site	O
of	O
translation	O
.	O

Identification	O
of	O
a	O
novel	O
family	O
of	O
targets	O
of	O
PYK2	O
related	O
to	O
Drosophila	O
retinal	O
degeneration	O
B	O
(	O
rdgB	B-Gene_or_gene_product
)	O
protein	O
.	O

The	O
protein	O
tyrosine	O
kinase	O
PYK2	O
has	O
been	O
implicated	O
in	O
signaling	O
pathways	O
activated	O
by	O
G	B-Gene_or_gene_product
-	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
-	I-Gene_or_gene_product
coupled	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
,	O
intracellular	O
calcium	O
,	O
and	O
stress	O
signals	O
.	O

Here	O
we	O
describe	O
the	O
molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
novel	O
family	O
of	O
PYK2	O
-	O
binding	O
proteins	O
designated	O
Nirs	B-Gene_or_gene_product
(	O
PYK2	O
N	O
-	O
terminal	O
domain	O
-	O
interacting	O
receptors	O
)	O
.	O

The	O
three	O
Nir	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
(	O
Nir1	B-Gene_or_gene_product
,	O
Nir2	B-Gene_or_gene_product
,	O
and	O
Nir3	B-Gene_or_gene_product
)	O
bind	O
to	O
the	O
amino	O
-	O
terminal	O
domain	O
of	O
PYK2	O
via	O
a	O
conserved	O
sequence	O
motif	O
located	O
in	O
the	O
carboxy	O
terminus	O
.	O

The	O
primary	O
structures	O
of	O
Nirs	B-Gene_or_gene_product
reveal	O
six	O
putative	O
transmembrane	O
domains	O
,	O
a	O
region	O
homologous	O
to	O
phosphatidylinositol	B-Gene_or_gene_product
(	I-Gene_or_gene_product
PI	I-Gene_or_gene_product
)	I-Gene_or_gene_product
transfer	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
and	O
an	O
acidic	O
domain	O
.	O

The	O
Nir	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
are	O
the	O
human	O
homologues	O
of	O
the	O
Drosophila	O
retinal	O
degeneration	O
B	O
protein	O
(	O
rdgB	B-Gene_or_gene_product
)	O
,	O
a	O
protein	B-Gene_or_gene_product
implicated	O
in	O
the	O
visual	O
transduction	O
pathway	O
in	O
flies	O
.	O

We	O
demonstrate	O
that	O
Nirs	B-Gene_or_gene_product
are	O
calcium	O
-	O
binding	O
proteins	B-Gene_or_gene_product
that	O
exhibit	O
PI	O
transfer	O
activity	O
in	O
vivo	O
.	O

Activation	O
of	O
PYK2	O
by	O
agents	O
that	O
elevate	O
intracellular	O
calcium	O
or	O
by	O
phorbol	O
ester	O
induce	O
tyrosine	O
phosphorylation	O
of	O
Nirs	B-Gene_or_gene_product
.	O

Moreover	O
,	O
PYK2	O
and	O
Nirs	B-Gene_or_gene_product
exhibit	O
similar	O
expression	O
patterns	O
in	O
several	O
regions	O
of	O
the	O
brain	O
and	O
retina	O
.	O

In	O
addition	O
,	O
PYK2	O
-	O
Nir	B-Gene_or_gene_product
complexes	O
are	O
detected	O
in	O
lysates	O
prepared	O
from	O
cultured	O
cells	O
or	O
from	O
brain	O
tissues	O
.	O

Finally	O
,	O
the	O
Nir1	B-Gene_or_gene_product
-	O
encoding	O
gene	B-Gene_or_gene_product
is	O
located	O
at	O
human	O
chromosome	O
17p13	O
.	O
1	O
,	O
in	O
proximity	O
to	O
a	O
locus	O
responsible	O
for	O
several	O
human	O
retinal	O
diseases	O
.	O

We	O
propose	O
that	O
the	O
Nir	B-Gene_or_gene_product
and	O
rdgB	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
represent	O
a	O
new	O
family	O
of	O
evolutionarily	O
conserved	O
PYK2	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
that	O
play	O
a	O
role	O
in	O
the	O
control	O
of	O
calcium	O
and	O
phosphoinositide	O
metabolism	O
downstream	O
of	O
G	B-Gene_or_gene_product
-	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
-	I-Gene_or_gene_product
coupled	I-Gene_or_gene_product
receptors	I-Gene_or_gene_product
.	O

Genomic	O
organization	O
and	O
promoter	O
characterization	O
of	O
two	O
human	O
UHS	B-Gene_or_gene_product
keratin	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
.	O

TTD	O
is	O
a	O
rare	O
human	O
genetic	O
disease	O
caused	O
by	O
mutations	O
in	O
XPB	O
and	O
XPD	O
,	O
two	O
subunits	O
of	O
the	O
transcription	O
/	O
repair	O
factor	O
TFIIH	O
,	O
and	O
whose	O
outstanding	O
clinical	O
characteristic	O
is	O
a	O
lack	O
of	O
most	O
human	O
UHS	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
resulting	O
in	O
sulfur	O
-	O
deficient	O
brittle	O
hair	O
.	O

In	O
an	O
attempt	O
to	O
understand	O
this	O
transcription	O
defect	O
,	O
we	O
report	O
here	O
the	O
genomic	O
cloning	O
of	O
two	O
highly	O
related	O
UHS	B-Gene_or_gene_product
keratin	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
specifically	O
expressed	O
in	O
follicular	O
and	O
epidermal	O
cells	O
.	O

In	O
addition	O
to	O
a	O
high	O
degree	O
of	O
nucleotide	O
homology	O
(	O
87	O
%	O
)	O
,	O
both	O
genes	B-Gene_or_gene_product
also	O
have	O
a	O
similar	O
90	O
-	O
nt	O
promoter	O
sequence	O
.	O

In	O
-	O
vivo	O
and	O
in	O
-	O
vitro	O
studies	O
allowed	O
us	O
to	O
specify	O
the	O
position	O
of	O
the	O
start	O
sites	O
,	O
the	O
TATA	O
-	O
boxes	O
and	O
some	O
regulatory	O
regions	O
.	O

Results	O
indicate	O
that	O
both	O
genes	B-Gene_or_gene_product
present	O
common	O
features	O
in	O
the	O
regulation	O
of	O
their	O
transcription	O
and	O
suggest	O
that	O
control	O
of	O
their	O
expression	O
might	O
be	O
affected	O
by	O
mutations	O
in	O
TFIIH	O
subunits	O
.	O

The	O
human	O
genome	O
has	O
only	O
one	O
functional	O
hsp47	O
gene	O
(	O
CBP2	B-Gene_or_gene_product
)	O
and	O
a	O
pseudogene	O
(	O
pshsp47	B-Gene_or_gene_product
)	O
.	O

Among	O
all	O
the	O
species	O
investigated	O
to	O
date	O
,	O
only	O
in	O
humans	O
is	O
hsp47	B-Gene_or_gene_product
reported	O
to	O
exist	O
as	O
two	O
separate	O
genes	B-Gene_or_gene_product
.	O

Here	O
we	O
examined	O
whether	O
hsp47	B-Gene_or_gene_product
forms	O
a	O
gene	O
family	O
,	O
and	O
if	O
so	O
,	O
how	O
many	O
genes	B-Gene_or_gene_product
constitute	O
the	O
family	O
.	O

Cloning	O
and	O
sequencing	O
of	O
human	O
hsp47	B-Gene_or_gene_product
cDNA	O
revealed	O
that	O
only	O
one	O
gene	B-Gene_or_gene_product
,	O
identical	O
to	O
CBP2	B-Gene_or_gene_product
,	O
was	O
transcribed	O
.	O

No	O
transcript	O
corresponding	O
to	O
colligin	B-Gene_or_gene_product
,	O
which	O
was	O
reported	O
to	O
be	O
a	O
human	O
homologue	O
of	O
hsp47	B-Gene_or_gene_product
,	O
was	O
found	O
.	O

Genomic	O
southern	O
hybridization	O
using	O
the	O
exon	O
III	O
fragment	O
of	O
mouse	O
hsp47	B-Gene_or_gene_product
as	O
a	O
probe	O
,	O
however	O
,	O
showed	O
two	O
bands	O
for	O
several	O
restriction	O
enzyme	O
digests	O
.	O

We	O
cloned	O
and	O
sequenced	O
the	O
gene	B-Gene_or_gene_product
corresponding	O
to	O
the	O
extra	O
band	O
and	O
found	O
that	O
a	O
pseudogene	O
(	O
pshsp47	B-Gene_or_gene_product
)	O
existed	O
in	O
the	O
human	O
genome	O
.	O

We	O
have	O
mapped	O
this	O
pseudogene	B-Gene_or_gene_product
to	O
chromosome	O
9p12	O
-	O
p13	O
by	O
fluorescent	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
using	O
a	O
3	O
.	O
5kb	O
genomic	O
fragment	O
containing	O
the	O
entire	O
pshsp47	B-Gene_or_gene_product
sequence	O
as	O
a	O
probe	O
.	O

These	O
results	O
suggested	O
that	O
functional	O
hsp47	B-Gene_or_gene_product
exists	O
as	O
CBP2	B-Gene_or_gene_product
,	O
not	O
as	O
colligin	B-Gene_or_gene_product
,	O
and	O
a	O
highly	O
conserved	O
pseudogene	B-Gene_or_gene_product
is	O
present	O
in	O
the	O
human	O
genome	O
.	O

Duet	O
is	O
a	O
novel	O
serine	O
/	O
threonine	O
kinase	O
with	O
Dbl	O
-	O
Homology	O
(	O
DH	O
)	O
and	O
Pleckstrin	O
-	O
Homology	O
(	O
PH	O
)	O
domains	O
.	O

We	O
show	O
here	O
the	O
identification	O
of	O
Duet	O
,	O
a	O
novel	O
molecule	O
bearing	O
serine	O
/	O
threonine	O
kinase	O
,	O
Dbl	O
-	O
Homology	O
(	O
DH	O
)	O
,	O
and	O
Pleckstrin	O
-	O
Homology	O
(	O
PH	O
)	O
domains	O
.	O

The	O
kinase	O
domain	O
of	O
Duet	O
shows	O
a	O
homology	O
to	O
that	O
of	O
DAP	O
kinase	O
that	O
is	O
involved	O
in	O
apoptosis	O
,	O
and	O
Duet	O
is	O
autophosphorylated	O
by	O
an	O
in	O
-	O
vitro	O
kinase	O
assay	O
.	O

The	O
DH	O
-	O
and	O
PH	O
-	O
domains	O
are	O
closely	O
related	O
to	O
those	O
of	O
Trio	B-Gene_or_gene_product
and	O
Kalirin	B-Gene_or_gene_product
.	O

Trad	O
mRNA	O
is	O
specifically	O
expressed	O
in	O
skeletal	O
muscle	O
.	O

Duet	O
protein	O
was	O
localized	O
to	O
actin	B-Gene_or_gene_product
-	O
associated	O
cytoskeletal	O
elements	O
.	O

These	O
data	O
suggest	O
a	O
role	O
of	O
Duet	O
in	O
the	O
cytoskeleton	O
-	O
dependent	O
cell	O
function	O
.	O

Molecular	O
cloning	O
of	O
cDNA	O
encoding	O
human	O
Rab3D	B-Gene_or_gene_product
whose	O
expression	O
is	O
upregulated	O
with	O
myeloid	O
differentiation	O
.	O

To	O
identify	O
genes	B-Gene_or_gene_product
expressed	O
in	O
myeloid	O
differentiation	O
,	O
we	O
isolated	O
a	O
cDNA	O
fragment	O
by	O
differential	O
display	O
using	O
RNA	O
prepared	O
from	O
HT93A	O
cells	O
,	O
a	O
human	O
cell	O
line	O
capable	O
of	O
differentiating	O
into	O
neutrophil	O
and	O
eosinophil	O
lineages	O
in	O
response	O
to	O
retinoic	O
acid	O
(	O
RA	O
)	O
.	O

Evaluation	O
of	O
the	O
full	O
-	O
length	O
clone	O
isolated	O
from	O
an	O
HT93A	O
cDNA	O
library	O
showed	O
that	O
it	O
encoded	O
a	O
24	O
kDa	O
protein	B-Gene_or_gene_product
comprised	O
of	O
several	O
domains	O
conserved	O
in	O
the	O
Ras	B-Gene_or_gene_product
superfamily	O
.	O

Comparison	O
of	O
the	O
deduced	O
amino	O
acid	O
sequence	O
of	O
this	O
clone	O
with	O
Rab	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
revealed	O
that	O
it	O
had	O
highest	O
homology	O
to	O
a	O
small	O
GTP	O
-	O
binding	O
protein	B-Gene_or_gene_product
,	O
murine	O
Rab3D	B-Gene_or_gene_product
.	O

The	O
mRNA	O
expression	O
of	O
human	O
Rab3D	B-Gene_or_gene_product
was	O
upregulated	O
in	O
the	O
course	O
of	O
myeloid	O
differentiation	O
,	O
and	O
it	O
was	O
preferentially	O
expressed	O
in	O
granulocytes	O
.	O

These	O
results	O
suggest	O
that	O
human	O
Rab3D	B-Gene_or_gene_product
may	O
play	O
a	O
specific	O
role	O
in	O
granulocytes	O
,	O
for	O
example	O
in	O
exocytosis	O
of	O
neutrophil	O
-	O
specific	O
granules	O
or	O
in	O
degranulation	O
of	O
both	O
eosinophils	O
and	O
basophils	O
.	O

Physical	O
interaction	O
of	O
the	O
bHLH	O
LYL1	O
protein	O
and	O
NF	O
-	O
kappaB1	O
p105	O
.	O

The	O
LYL1	O
gene	B-Gene_or_gene_product
was	O
first	O
identified	O
upon	O
the	O
molecular	O
characterization	O
of	O
the	O
t	O
(	O
7	O
;	O
9	O
)	O
(	O
q35	O
;	O
p13	O
)	O
translocation	O
associated	O
with	O
some	O
human	O
T	O
-	O
cell	O
acute	O
leukemias	O
(	O
T	O
-	O
ALLs	O
)	O
.	O

In	O
adult	O
tissues	O
,	O
LYL1	O
expression	O
is	O
restricted	O
to	O
hematopoietic	O
cells	O
with	O
the	O
notable	O
exclusion	O
of	O
the	O
T	O
cell	O
lineage	O
.	O

LYL1	B-Gene_or_gene_product
encodes	O
a	O
basic	O
helix	O
-	O
loop	O
-	O
helix	O
(	O
bHLH	O
)	O
protein	O
highly	O
related	O
to	O
TAL	O
-	O
1	O
,	O
whose	O
activation	O
is	O
also	O
associated	O
with	O
a	O
high	O
proportion	O
of	O
human	O
T	O
-	O
ALLs	O
.	O

A	O
yeast	O
two	O
-	O
hybrid	O
system	O
was	O
used	O
to	O
identify	O
proteins	B-Gene_or_gene_product
that	O
specifically	O
interact	O
with	O
LYL1	O
and	O
might	O
mediate	O
its	O
activities	O
.	O

We	O
found	O
that	O
p105	O
,	O
the	O
precursor	O
of	O
NF	O
-	O
kappaB1	O
p50	O
,	O
was	O
the	O
major	O
LYL1	O
-	O
interacting	O
protein	B-Gene_or_gene_product
in	O
this	O
system	O
.	O

The	O
association	O
between	O
LYL1	O
and	O
p105	O
was	O
confirmed	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
in	O
mammalian	O
cells	O
.	O

Biochemical	O
studies	O
indicated	O
that	O
the	O
interaction	O
was	O
mediated	O
by	O
the	O
bHLH	O
motif	O
of	O
LYL1	O
and	O
the	O
ankyrin	O
-	O
like	O
motifs	O
of	O
p105	B-Gene_or_gene_product
.	O

Ectopic	O
expression	O
of	O
LYL1	O
in	O
a	O
human	O
T	O
cell	O
line	O
caused	O
a	O
significant	O
decrease	O
in	O
NF	O
-	O
kappaB	O
-	O
dependent	O
transcription	O
,	O
associated	O
with	O
a	O
reduced	O
level	O
of	O
NF	O
-	O
kappaB1	O
proteins	O
.	O

RFLAT	O
-	O
1	O
:	O
a	O
new	O
zinc	O
finger	O
transcription	O
factor	O
that	O
activates	O
RANTES	B-Gene_or_gene_product
gene	O
expression	O
in	O
T	O
lymphocytes	O
.	O

RANTES	B-Gene_or_gene_product
(	O
Regulated	O
upon	O
Activation	O
,	O
Normal	O
T	O
cell	O
Expressed	O
and	O
Secreted	O
)	O
is	O
a	O
chemoattractant	O
cytokine	B-Gene_or_gene_product
(	O
chemokine	B-Gene_or_gene_product
)	O
important	O
in	O
the	O
generation	O
of	O
inflammatory	O
infiltrate	O
and	O
human	O
immunodeficiency	O
virus	O
entry	O
into	O
immune	O
cells	O
.	O

RANTES	B-Gene_or_gene_product
is	O
expressed	O
late	O
(	O
3	O
-	O
5	O
days	O
)	O
after	O
activation	O
in	O
T	O
lymphocytes	O
.	O

Using	O
expression	O
cloning	O
,	O
we	O
identified	O
the	O
first	O
"	O
late	O
"	O
T	O
lymphocyte	O
associated	O
transcription	O
factor	O
and	O
named	O
it	O
"	O
RANTES	O
Factor	O
of	O
Late	O
Activated	O
T	O
Lymphocytes	O
-	O
1	O
"	O
(	O
RFLAT	O
-	O
1	O
)	O
.	O

RFLAT	O
-	O
1	O
is	O
a	O
novel	O
,	O
phosphorylated	O
,	O
zinc	O
finger	O
transcription	O
factor	O
that	O
is	O
expressed	O
in	O
T	O
cells	O
3	O
days	O
after	O
activation	O
,	O
coincident	O
with	O
RANTES	O
expression	O
.	O

While	O
Rel	O
proteins	O
play	O
the	O
dominant	O
role	O
in	O
RANTES	B-Gene_or_gene_product
gene	O
expression	O
in	O
fibroblasts	O
,	O
RFLAT	O
-	O
1	O
is	O
a	O
strong	O
transactivator	O
for	O
RANTES	B-Gene_or_gene_product
in	O
T	O
cells	O
.	O

Interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
18	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
:	O
a	O
novel	O
modulator	O
of	O
the	O
Th1	B-Gene_or_gene_product
cytokine	I-Gene_or_gene_product
response	O
.	O

An	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
18	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
18BP	I-Gene_or_gene_product
)	O
was	O
purified	O
from	O
urine	O
by	O
chromatography	O
on	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
18	I-Gene_or_gene_product
beads	O
,	O
sequenced	O
,	O
cloned	O
,	O
and	O
expressed	O
in	O
COS7	O
cells	O
.	O

IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
18BP	I-Gene_or_gene_product
abolished	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
18	I-Gene_or_gene_product
induction	O
of	O
interferon	B-Gene_or_gene_product
-	I-Gene_or_gene_product
gamma	I-Gene_or_gene_product
(	O
IFNgamma	B-Gene_or_gene_product
)	O
,	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
8	I-Gene_or_gene_product
,	O
and	O
activation	O
of	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
in	O
vitro	O
.	O

Administration	O
of	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
18BP	I-Gene_or_gene_product
to	O
mice	O
abrogated	O
circulating	O
IFNgamma	B-Gene_or_gene_product
following	O
LPS	O
.	O

Thus	O
,	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
18BP	I-Gene_or_gene_product
functions	O
as	O
an	O
inhibitor	O
of	O
the	O
early	O
Th1	B-Gene_or_gene_product
cytokine	I-Gene_or_gene_product
response	O
.	O

IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
18BP	I-Gene_or_gene_product
is	O
constitutively	O
expressed	O
in	O
the	O
spleen	O
,	O
belongs	O
to	O
the	O
immunoglobulin	B-Gene_or_gene_product
superfamily	O
,	O
and	O
has	O
limited	O
homology	O
to	O
the	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
type	I-Gene_or_gene_product
II	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
.	O

Its	O
gene	B-Gene_or_gene_product
was	O
localized	O
on	O
human	O
chromosome	O
11q13	O
,	O
and	O
no	O
exon	O
coding	O
for	O
a	O
transmembrane	O
domain	O
was	O
found	O
in	O
an	O
8	O
.	O
3	O
kb	O
genomic	O
sequence	O
.	O

Several	O
Poxviruses	O
encode	O
putative	O
proteins	B-Gene_or_gene_product
highly	O
homologous	O
to	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
18BP	I-Gene_or_gene_product
,	O
suggesting	O
that	O
viral	O
products	B-Gene_or_gene_product
may	O
attenuate	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
18	I-Gene_or_gene_product
and	O
interfere	O
with	O
the	O
cytotoxic	O
T	O
cell	O
response	O
.	O

Rpp14	O
and	O
Rpp29	O
,	O
two	O
protein	O
subunits	O
of	O
human	O
ribonuclease	O
P	O
.	O

In	O
HeLa	O
cells	O
,	O
the	O
tRNA	O
processing	O
enzyme	O
ribonuclease	O
P	O
(	O
RNase	O
P	O
)	O
consists	O
of	O
an	O
RNA	O
molecule	O
associated	O
with	O
at	O
least	O
eight	O
protein	O
subunits	O
,	O
hPop1	O
,	O
Rpp14	O
,	O
Rpp20	O
,	O
Rpp25	O
,	O
Rpp29	O
,	O
Rpp30	O
,	O
Rpp38	O
,	O
and	O
Rpp40	O
.	O

Five	O
of	O
these	O
proteins	B-Gene_or_gene_product
(	O
hPop1p	O
,	O
Rpp20	O
,	O
Rpp30	O
,	O
Rpp38	O
,	O
and	O
Rpp40	O
)	O
have	O
been	O
partially	O
characterized	O
.	O

Here	O
we	O
report	O
on	O
the	O
cDNA	O
cloning	O
and	O
immunobiochemical	O
analysis	O
of	O
Rpp14	O
and	O
Rpp29	O
.	O

Polyclonal	O
rabbit	O
antibodies	B-Gene_or_gene_product
raised	O
against	O
recombinant	O
Rpp14	O
and	O
Rpp29	O
recognize	O
their	O
corresponding	O
antigens	O
in	O
HeLa	O
cells	O
and	O
precipitate	O
catalytically	O
active	O
RNase	O
P	O
.	O

Rpp29	O
shows	O
23	O
%	O
identity	O
with	O
Pop4p	O
,	O
a	O
subunit	O
of	O
yeast	O
nuclear	O
RNase	O
P	O
and	O
the	O
ribosomal	O
RNA	O
processing	O
enzyme	O
RNase	O
MRP	O
.	O

Rpp14	O
,	O
by	O
contrast	O
,	O
exhibits	O
no	O
significant	O
homology	O
to	O
any	O
known	O
yeast	O
gene	B-Gene_or_gene_product
.	O

Thus	O
,	O
human	O
RNase	O
P	O
differs	O
in	O
the	O
details	O
of	O
its	O
protein	B-Gene_or_gene_product
composition	O
,	O
and	O
perhaps	O
in	O
the	O
functions	O
of	O
some	O
of	O
these	O
proteins	B-Gene_or_gene_product
,	O
from	O
the	O
yeast	O
enzyme	O
.	O

A	O
molecular	O
pathway	O
revealing	O
a	O
genetic	O
basis	O
for	O
human	O
cardiac	O
and	O
craniofacial	O
defects	O
.	O

Microdeletions	O
of	O
chromosome	O
22q11	O
are	O
the	O
most	O
common	O
genetic	O
defects	O
associated	O
with	O
cardiac	O
and	O
craniofacial	O
anomalies	O
in	O
humans	O
.	O

A	O
screen	O
for	O
mouse	O
genes	B-Gene_or_gene_product
dependent	O
on	O
dHAND	O
,	O
a	O
transcription	O
factor	O
implicated	O
in	O
neural	O
crest	O
development	O
,	O
identified	O
Ufd1	B-Gene_or_gene_product
,	O
which	O
maps	O
to	O
human	O
22q11	O
and	O
encodes	O
a	O
protein	B-Gene_or_gene_product
involved	O
in	O
degradation	O
of	O
ubiquitinated	O
proteins	B-Gene_or_gene_product
.	O

Mouse	O
Ufd1	B-Gene_or_gene_product
was	O
specifically	O
expressed	O
in	O
most	O
tissues	O
affected	O
in	O
patients	O
with	O
22q11	O
deletion	O
syndrome	O
.	O

The	O
human	O
UFD1L	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
was	O
deleted	O
in	O
all	O
182	O
patients	O
studied	O
with	O
22q11	O
deletion	O
,	O
and	O
a	O
smaller	O
deletion	O
of	O
approximately	O
20	O
kilobases	O
that	O
removed	O
exons	O
1	O
to	O
3	O
of	O
UFD1L	B-Gene_or_gene_product
was	O
found	O
in	O
one	O
individual	O
with	O
features	O
typical	O
of	O
22q11	O
deletion	O
syndrome	O
.	O

These	O
data	O
suggest	O
that	O
UFD1L	B-Gene_or_gene_product
haploinsufficiency	O
contributes	O
to	O
the	O
congenital	O
heart	O
and	O
craniofacial	O
defects	O
seen	O
in	O
22q11	O
deletion	O
.	O

Mutations	O
in	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
myosin	I-Gene_or_gene_product
S2	I-Gene_or_gene_product
that	O
cause	O
familial	O
hypertrophic	O
cardiomyopathy	O
(	O
FHC	O
)	O
abolish	O
the	O
interaction	O
with	O
the	O
regulatory	O
domain	O
of	O
myosin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
-	I-Gene_or_gene_product
C	I-Gene_or_gene_product
.	O

The	O
myosin	B-Gene_or_gene_product
filaments	O
of	O
striated	O
muscle	O
contain	O
a	O
family	O
of	O
enigmatic	O
myosin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
(	O
MyBP	B-Gene_or_gene_product
)	O
,	O
MyBP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
C	I-Gene_or_gene_product
and	O
MyBP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
H	I-Gene_or_gene_product
.	O

These	O
modular	O
proteins	B-Gene_or_gene_product
of	O
the	O
intracellular	O
immunoglobulin	B-Gene_or_gene_product
superfamily	O
contain	O
unique	O
domains	O
near	O
their	O
N	O
termini	O
.	O

The	O
N	O
-	O
terminal	O
domain	O
of	O
cardiac	O
MyBP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
C	I-Gene_or_gene_product
,	O
the	O
MyBP	O
-	O
C	O
motif	O
,	O
contains	O
additional	O
phosphorylation	O
sites	O
and	O
may	O
regulate	O
contraction	O
in	O
a	O
phosphorylation	O
dependent	O
way	O
.	O

In	O
contrast	O
to	O
the	O
C	O
terminus	O
,	O
which	O
binds	O
to	O
the	O
light	O
meromyosin	O
portion	O
of	O
the	O
myosin	B-Gene_or_gene_product
rod	I-Gene_or_gene_product
,	O
the	O
interactions	O
of	O
this	O
domain	O
are	O
unknown	O
.	O

We	O
demonstrate	O
that	O
fragments	O
of	O
MyBP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
C	I-Gene_or_gene_product
containing	O
the	O
MyBP	O
-	O
C	O
motif	O
localise	O
to	O
the	O
sarcomeric	O
A	O
-	O
band	O
in	O
cardiomyocytes	O
and	O
isolated	O
myofibrils	O
,	O
without	O
affecting	O
sarcomere	O
structure	O
.	O

The	O
binding	O
site	O
for	O
the	O
MyBP	O
-	O
C	O
motif	O
resides	O
in	O
the	O
N	O
-	O
terminal	O
126	O
residues	O
of	O
the	O
S2	O
segment	O
of	O
the	O
myosin	B-Gene_or_gene_product
rod	I-Gene_or_gene_product
.	O

In	O
this	O
region	O
,	O
several	O
mutations	O
in	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
myosin	I-Gene_or_gene_product
are	O
associated	O
with	O
FHC	O
;	O
however	O
,	O
their	O
molecular	O
implications	O
remained	O
unclear	O
.	O

We	O
show	O
that	O
two	O
representative	O
FHC	O
mutations	O
in	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
myosin	I-Gene_or_gene_product
S2	I-Gene_or_gene_product
,	O
R870H	O
and	O
E924K	O
,	O
drastically	O
reduce	O
MyBP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
C	I-Gene_or_gene_product
binding	O
(	O
Kd	O
approximately	O
60	O
microM	O
for	O
R870H	O
compared	O
with	O
a	O
Kd	O
of	O
approximately	O
5	O
microM	O
for	O
the	O
wild	O
-	O
type	O
)	O
down	O
to	O
undetectable	O
levels	O
(	O
E924K	O
)	O
.	O

These	O
mutations	O
do	O
not	O
affect	O
the	O
coiled	O
-	O
coil	O
structure	O
of	O
myosin	B-Gene_or_gene_product
.	O

We	O
suggest	O
that	O
the	O
regulatory	O
function	O
of	O
MyBP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
C	I-Gene_or_gene_product
is	O
mediated	O
by	O
the	O
interaction	O
with	O
S2	B-Gene_or_gene_product
,	O
and	O
that	O
mutations	O
in	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
myosin	I-Gene_or_gene_product
S2	I-Gene_or_gene_product
may	O
act	O
by	O
altering	O
the	O
interactions	O
with	O
MyBP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
C	I-Gene_or_gene_product
.	O

Complete	O
sequence	O
of	O
the	O
human	O
mucin	B-Gene_or_gene_product
MUC4	B-Gene_or_gene_product
:	O
a	O
putative	O
cell	O
membrane	O
-	O
associated	O
mucin	B-Gene_or_gene_product
.	O

The	O
MUC4	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
,	O
which	O
encodes	O
a	O
human	O
epithelial	B-Gene_or_gene_product
mucin	I-Gene_or_gene_product
,	O
is	O
expressed	O
in	O
various	O
epithelial	O
tissues	O
,	O
just	O
as	O
well	O
in	O
adult	O
as	O
in	O
poorly	O
differentiated	O
cells	O
in	O
the	O
embryo	O
and	O
fetus	O
.	O

Its	O
N	O
-	O
terminus	O
and	O
central	O
sequences	O
have	O
previously	O
been	O
reported	O
as	O
comprising	O
a	O
27	O
-	O
residue	O
peptide	O
signal	O
,	O
followed	O
by	O
a	O
large	O
domain	O
varying	O
in	O
length	O
from	O
3285	O
to	O
7285	O
amino	O
acid	O
residues	O
.	O

The	O
present	O
study	O
establishes	O
the	O
whole	O
coding	O
sequence	O
of	O
MUC4	B-Gene_or_gene_product
in	O
which	O
the	O
C	O
-	O
terminus	O
is	O
1156	O
amino	O
acid	O
residues	O
long	O
and	O
shares	O
a	O
high	O
degree	O
of	O
similarity	O
with	O
the	O
rat	O
sialomucin	O
complex	O
(	O
SMC	O
)	O
.	O

SMC	O
is	O
a	O
heterodimeric	O
glycoprotein	O
complex	O
composed	O
of	O
mucin	B-Gene_or_gene_product
(	O
ascites	B-Gene_or_gene_product
sialoglycoprotein	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
ASGP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
and	O
transmembrane	O
(	O
ASGP	O
-	O
2	O
)	O
subunits	O
.	O

The	O
same	O
organization	O
is	O
found	O
in	O
MUC4	B-Gene_or_gene_product
,	O
where	O
the	O
presence	O
of	O
a	O
GlyAspProHis	O
proteolytic	O
site	O
may	O
cleave	O
the	O
large	O
precursor	O
into	O
two	O
subunits	O
,	O
MUC4alpha	O
and	O
MUC4beta	O
.	O

Like	O
ASGP	O
-	O
2	O
,	O
which	O
binds	O
the	O
receptor	O
tyrosine	O
kinase	O
p185	O
(	O
neu	O
)	O
,	O
MUC4beta	O
possesses	O
two	O
epidermal	O
growth	O
factor	O
-	O
like	O
domains	O
,	O
a	O
transmembrane	O
sequence	O
and	O
a	O
potential	O
phosphorylated	O
site	O
.	O

MUC4	O
,	O
the	O
human	O
homologue	O
of	O
rat	O
SMC	O
,	O
may	O
be	O
a	O
heterodimeric	O
bifunctional	O
cell	O
-	O
surface	O
glycoprotein	B-Gene_or_gene_product
of	O
2	O
.	O
12	O
micrometers	O
.	O

These	O
results	O
confer	O
a	O
new	O
biological	O
role	O
for	O
MUC4	B-Gene_or_gene_product
as	O
a	O
ligand	O
for	O
ErbB2	B-Gene_or_gene_product
in	O
cell	O
signalling	O
.	O

Update	O
on	O
interconversions	O
of	O
vitamin	O
B	O
-	O
6	O
with	O
its	O
coenzyme	O
.	O

Biosynthesis	O
of	O
pyridoxal	O
5	O
'	O
-	O
phosphate	O
(	O
PLP	O
)	O
depends	O
upon	O
the	O
relatively	O
specific	O
action	O
of	O
two	O
consecutive	O
enzymes	O
,	O
viz	O
.	O
pyridoxal	O
(	O
pyridoxine	O
,	O
pyridoxamine	O
)	O
kinase	O
and	O
pyridoxine	O
(	O
pyridoxamine	O
)	O
phosphate	O
oxidase	O
.	O

Less	O
specific	O
phosphatases	O
catalyze	O
hydrolyses	O
of	O
the	O
5	O
'	O
-	O
phosphates	O
of	O
the	O
vitamers	O
pyridoxal	O
,	O
pyridoxamine	O
,	O
and	O
pyridoxine	O
.	O

From	O
the	O
recognition	O
a	O
generation	O
ago	O
of	O
these	O
processes	O
by	O
which	O
the	O
three	O
forms	O
of	O
vitamin	O
B	O
-	O
6	O
and	O
their	O
5	O
'	O
-	O
phosphates	O
are	O
interconverted	O
,	O
more	O
recent	O
studies	O
have	O
provided	O
a	O
fairly	O
sophisticated	O
understanding	O
of	O
the	O
molecular	O
characteristics	O
of	O
the	O
enzymes	O
involved	O
.	O

The	O
evolutionary	O
retention	O
of	O
homologous	O
portions	O
of	O
pyridoxal	O
kinase	O
in	O
humans	O
as	O
well	O
as	O
bacteria	O
and	O
the	O
most	O
recent	O
finding	O
of	O
a	O
highly	O
conserved	O
region	O
of	O
the	O
pyridoxine	O
(	O
pyridoxamine	O
)	O
phosphate	O
oxidase	O
,	O
also	O
from	O
both	O
prokaryotic	O
and	O
eukaryotic	O
organisms	O
,	O
emphasize	O
the	O
importance	O
of	O
these	O
catalysts	O
in	O
the	O
formation	O
of	O
a	O
coenzyme	O
that	O
is	O
essential	O
for	O
most	O
organisms	O
.	O

Both	O
kinase	O
and	O
oxidase	O
involved	O
in	O
B	O
-	O
6	O
metabolism	O
are	O
potential	O
targets	O
for	O
pharmacologic	O
agents	O
.	O

Tissue	O
specific	O
expression	O
and	O
chromosomal	O
mapping	O
of	O
a	O
human	O
UDP	O
-	O
N	O
-	O
acetylglucosamine	O
:	O
alpha1	O
,	O
3	O
-	O
d	O
-	O
mannoside	O
beta1	O
,	O
4	O
-	O
N	O
-	O
acetylglucosaminyltransferase	O
.	O

A	O
human	O
cDNA	O
for	O
UDP	O
-	O
N	O
-	O
acetylglucosamine	O
:	O
alpha1	O
,	O
3	O
-	O
d	O
-	O
mannoside	O
beta1	O
,	O
4	O
-	O
N	O
-	O
acetylglucosaminyltransferase	O
(	O
GnT	O
-	O
IV	O
)	O
was	O
isolated	O
from	O
a	O
liver	O
cDNA	O
library	O
using	O
a	O
probe	O
based	O
on	O
a	O
partial	O
cDNA	O
sequence	O
of	O
the	O
bovine	O
GnT	O
-	O
IV	O
.	O

The	O
cDNA	O
encoded	O
a	O
complete	O
sequence	O
of	O
a	O
type	B-Gene_or_gene_product
II	I-Gene_or_gene_product
membrane	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
of	O
535	O
amino	O
acids	O
which	O
is	O
96	O
%	O
identical	O
to	O
the	O
bovine	O
GnT	O
-	O
IV	O
.	O

Transient	O
expression	O
of	O
the	O
human	O
cDNA	O
in	O
COS7	O
cells	O
increased	O
total	O
cellular	O
GnT	O
-	O
IV	O
activity	O
25	O
-	O
fold	O
,	O
demonstrating	O
that	O
this	O
cDNA	O
encodes	O
a	O
functional	O
human	O
GnT	O
-	O
IV	O
.	O

Northern	O
blot	O
analysis	O
of	O
normal	O
tissues	O
indicated	O
that	O
at	O
least	O
five	O
different	O
sizes	O
of	O
mRNA	O
(	O
9	O
.	O
7	O
,	O
7	O
.	O
6	O
,	O
5	O
.	O
1	O
,	O
3	O
.	O
8	O
,	O
and	O
2	O
.	O
4	O
kb	O
)	O
forGnT	O
-	O
IV	O
are	O
expressed	O
in	O
vivo	O
.	O

Furthermore	O
,	O
these	O
mRNAs	O
are	O
expressed	O
at	O
different	O
levels	O
between	O
tissues	O
.	O

Large	O
amounts	O
of	O
mRNA	O
were	O
detected	O
in	O
tissues	O
harboring	O
T	O
lineage	O
cells	O
.	O

Also	O
,	O
the	O
promyelocytic	O
leukemia	O
cell	O
line	O
HL	O
-	O
60	O
and	O
the	O
lymphoblastic	O
leukemia	O
cell	O
line	O
MOLT	O
-	O
4	O
revealed	O
abundant	O
mRNA	O
.	O

Lastly	O
,	O
the	O
gene	B-Gene_or_gene_product
was	O
mapped	O
at	O
the	O
locus	O
on	O
human	O
chromosome	O
2	O
,	O
band	O
q12	O
by	O
fluorescent	O
in	O
situ	O
hybridization	O
.	O

Altered	O
trafficking	O
of	O
lysosomal	O
proteins	B-Gene_or_gene_product
in	O
Hermansky	O
-	O
Pudlak	O
syndrome	O
due	O
to	O
mutations	O
in	O
the	O
beta	O
3A	O
subunit	O
of	O
the	O
AP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
adaptor	I-Gene_or_gene_product
.	O

Hermansky	O
-	O
Pudlak	O
syndrome	O
(	O
HPS	O
)	O
is	O
a	O
genetic	O
disorder	O
characterized	O
by	O
defective	O
lysosome	O
-	O
related	O
organelles	O
.	O

Here	O
,	O
we	O
report	O
the	O
identification	O
of	O
two	O
HPS	O
patients	O
with	O
mutations	O
in	O
the	O
beta	O
3A	O
subunit	O
of	O
the	O
heterotetrameric	B-Gene_or_gene_product
AP	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
complex	I-Gene_or_gene_product
.	O

The	O
patients	O
'	O
fibroblasts	O
exhibit	O
drastically	O
reduced	O
levels	O
of	O
AP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
due	O
to	O
enhanced	O
degradation	O
of	O
mutant	O
beta	O
3A	O
.	O

The	O
AP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
deficiency	O
results	O
in	O
increased	O
surface	O
expression	O
of	O
the	O
lysosomal	B-Gene_or_gene_product
membrane	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
CD63	B-Gene_or_gene_product
,	O
lamp	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
and	O
lamp	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
but	O
not	O
of	O
nonlysosomal	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

These	O
differential	O
effects	O
are	O
consistent	O
with	O
the	O
preferential	O
interaction	O
of	O
the	O
AP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
mu	O
3A	O
subunit	O
with	O
tyrosine	O
-	O
based	O
signals	O
involved	O
in	O
lysosomal	O
targeting	O
.	O

Our	O
results	O
suggest	O
that	O
AP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
functions	O
in	O
protein	O
sorting	O
to	O
lysosomes	O
and	O
provide	O
an	O
example	O
of	O
a	O
human	O
disease	O
in	O
which	O
altered	O
trafficking	O
of	O
integral	B-Gene_or_gene_product
membrane	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
is	O
due	O
to	O
mutations	O
in	O
a	O
component	O
of	O
the	O
sorting	O
machinery	O
.	O

A	O
novel	O
human	O
SRB	B-Gene_or_gene_product
/	I-Gene_or_gene_product
MED	I-Gene_or_gene_product
-	O
containing	O
cofactor	O
complex	O
,	O
SMCC	O
,	O
involved	O
in	O
transcription	O
regulation	O
.	O

A	O
novel	O
human	O
complex	O
that	O
can	O
either	O
repress	O
activator	O
-	O
dependent	O
transcription	O
mediated	O
by	O
PC4	B-Gene_or_gene_product
,	O
or	O
,	O
at	O
limiting	O
TFIIH	O
,	O
act	O
synergistically	O
with	O
PC4	B-Gene_or_gene_product
to	O
enhance	O
activator	O
-	O
dependent	O
transcription	O
has	O
been	O
purified	O
.	O

This	O
complex	O
contains	O
homologs	O
of	O
a	O
subset	O
of	O
yeast	O
mediator	O
/	O
holoenzyme	O
components	O
(	O
including	O
SRB7	B-Gene_or_gene_product
,	O
SRB10	B-Gene_or_gene_product
,	O
SRB11	B-Gene_or_gene_product
,	O
MED6	B-Gene_or_gene_product
,	O
and	O
RGR1	B-Gene_or_gene_product
)	O
,	O
homologs	O
of	O
other	O
yeast	O
transcriptional	O
regulatory	O
factors	O
(	O
SOH1	O
and	O
NUT2	O
)	O
,	O
and	O
,	O
significantly	O
,	O
some	O
components	O
(	O
TRAP220	B-Gene_or_gene_product
,	O
TRAP170	B-Gene_or_gene_product
/	I-Gene_or_gene_product
hRGR1	I-Gene_or_gene_product
,	O
and	O
TRAP100	B-Gene_or_gene_product
)	O
of	O
a	O
human	O
thyroid	B-Gene_or_gene_product
hormone	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	O
associated	O
coactivator	O
complex	O
.	O

The	O
complex	O
shows	O
direct	O
activator	O
interactions	O
but	O
,	O
unlike	O
yeast	O
mediator	O
,	O
can	O
act	O
independently	O
of	O
the	O
RNA	O
polymerase	O
II	O
CTD	O
.	O

These	O
findings	O
demonstrate	O
both	O
positive	O
and	O
negative	O
functional	O
capabilities	O
for	O
the	O
human	O
complex	O
,	O
emphasize	O
novel	O
(	O
CTD	O
-	O
independent	O
)	O
regulatory	O
mechanisms	O
,	O
and	O
link	O
the	O
complex	O
to	O
other	O
human	O
coactivator	O
complexes	O
.	O

Regulation	O
of	O
histone	O
acetyltransferases	O
p300	O
and	O
PCAF	O
by	O
the	O
bHLH	O
protein	O
twist	B-Gene_or_gene_product
and	O
adenoviral	O
oncoprotein	B-Gene_or_gene_product
E1A	B-Gene_or_gene_product
.	O

Histone	O
acetyltransferases	O
(	O
HAT	O
)	O
play	O
a	O
critical	O
role	O
in	O
transcriptional	O
control	O
by	O
relieving	O
repressive	O
effects	O
of	O
chromatin	O
,	O
and	O
yet	O
how	O
HATs	O
themselves	O
are	O
regulated	O
remains	O
largely	O
unknown	O
.	O

Here	O
,	O
it	O
is	O
shown	O
that	O
Twist	B-Gene_or_gene_product
directly	O
binds	O
two	O
independent	O
HAT	O
domains	O
of	O
acetyltransferases	O
,	O
p300	O
and	O
p300	O
/	O
CBP	O
-	O
associated	O
factor	O
(	O
PCAF	O
)	O
,	O
and	O
directly	O
regulates	O
their	O
HAT	O
activities	O
.	O

The	O
N	O
terminus	O
of	O
Twist	B-Gene_or_gene_product
is	O
a	O
primary	O
domain	O
interacting	O
with	O
both	O
acetyltransferases	O
,	O
and	O
the	O
same	O
domain	O
is	O
required	O
for	O
inhibition	O
of	O
p300	O
-	O
dependent	O
transcription	O
by	O
Twist	B-Gene_or_gene_product
.	O

Adenovirus	O
E1A	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
mimics	O
the	O
effects	O
of	O
Twist	B-Gene_or_gene_product
by	O
inhibiting	O
the	O
HAT	O
activities	O
of	O
p300	O
and	O
PCAF	O
.	O

These	O
findings	O
establish	O
a	O
cogent	O
argument	O
for	O
considering	O
the	O
HAT	O
domains	O
as	O
a	O
direct	O
target	O
for	O
acetyltransferase	O
regulation	O
by	O
both	O
a	O
cellular	O
transcription	O
factor	O
and	O
a	O
viral	O
oncoprotein	B-Gene_or_gene_product
.	O

KCNQ4	B-Gene_or_gene_product
,	O
a	O
novel	O
potassium	B-Gene_or_gene_product
channel	I-Gene_or_gene_product
expressed	O
in	O
sensory	O
outer	O
hair	O
cells	O
,	O
is	O
mutated	O
in	O
dominant	O
deafness	O
.	O

Potassium	B-Gene_or_gene_product
channels	I-Gene_or_gene_product
regulate	O
electrical	O
signaling	O
and	O
the	O
ionic	O
composition	O
of	O
biological	O
fluids	O
.	O

Mutations	O
in	O
the	O
three	O
known	O
genes	B-Gene_or_gene_product
of	O
the	O
KCNQ	B-Gene_or_gene_product
branch	O
of	O
the	O
K	B-Gene_or_gene_product
+	I-Gene_or_gene_product
channel	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
family	O
underlie	O
inherited	O
cardiac	O
arrhythmias	O
(	O
in	O
some	O
cases	O
associated	O
with	O
deafness	O
)	O
and	O
neonatal	O
epilepsy	O
.	O

We	O
have	O
now	O
cloned	O
KCNQ4	B-Gene_or_gene_product
,	O
a	O
novel	O
member	O
of	O
this	O
branch	O
.	O

It	O
maps	O
to	O
the	O
DFNA2	O
locus	O
for	O
a	O
form	O
of	O
nonsyndromic	O
dominant	O
deafness	O
.	O

In	O
the	O
cochlea	O
,	O
it	O
is	O
expressed	O
in	O
sensory	O
outer	O
hair	O
cells	O
.	O

A	O
mutation	O
in	O
this	O
gene	B-Gene_or_gene_product
in	O
a	O
DFNA2	O
pedigree	O
changes	O
a	O
residue	O
in	O
the	O
KCNQ4	B-Gene_or_gene_product
pore	O
region	O
.	O

It	O
abolishes	O
the	O
potassium	O
currents	O
of	O
wild	B-Gene_or_gene_product
-	I-Gene_or_gene_product
type	I-Gene_or_gene_product
KCNQ4	I-Gene_or_gene_product
on	O
which	O
it	O
exerts	O
a	O
strong	O
dominant	O
-	O
negative	O
effect	O
.	O

Whereas	O
mutations	O
in	O
KCNQ1	B-Gene_or_gene_product
cause	O
deafness	O
by	O
affecting	O
endolymph	O
secretion	O
,	O
the	O
mechanism	O
leading	O
to	O
KCNQ4	B-Gene_or_gene_product
-	O
related	O
hearing	O
loss	O
is	O
intrinsic	O
to	O
outer	O
hair	O
cells	O
.	O

A	O
thyroid	B-Gene_or_gene_product
hormone	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
coactivator	I-Gene_or_gene_product
negatively	O
regulated	O
by	O
the	O
retinoblastoma	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

The	O
retinoblastoma	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
Rb	B-Gene_or_gene_product
)	O
plays	O
a	O
critical	O
role	O
in	O
cell	O
proliferation	O
,	O
differentiation	O
,	O
and	O
development	O
.	O

To	O
decipher	O
the	O
mechanism	O
of	O
Rb	B-Gene_or_gene_product
function	O
at	O
the	O
molecular	O
level	O
,	O
we	O
have	O
systematically	O
characterized	O
a	O
number	O
of	O
Rb	B-Gene_or_gene_product
-	I-Gene_or_gene_product
interacting	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
,	O
among	O
which	O
is	O
the	O
clone	O
C5	O
described	O
here	O
,	O
which	O
encodes	O
a	O
protein	B-Gene_or_gene_product
of	O
1	O
,	O
978	O
amino	O
acids	O
with	O
an	O
estimated	O
molecular	O
mass	O
of	O
230	O
kDa	O
.	O

The	O
corresponding	O
gene	B-Gene_or_gene_product
was	O
assigned	O
to	O
chromosome	O
14q31	O
,	O
the	O
same	O
region	O
where	O
genetic	O
alterations	O
have	O
been	O
associated	O
with	O
several	O
abnormalities	O
of	O
thyroid	O
hormone	O
response	O
.	O

The	O
protein	B-Gene_or_gene_product
uses	O
two	O
distinct	O
regions	O
to	O
bind	O
Rb	B-Gene_or_gene_product
and	O
thyroid	B-Gene_or_gene_product
hormone	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	O
TR	B-Gene_or_gene_product
)	O
,	O
respectively	O
,	O
and	O
thus	O
was	O
named	O
Trip230	B-Gene_or_gene_product
.	O

Trip230	B-Gene_or_gene_product
binds	O
to	O
Rb	B-Gene_or_gene_product
independently	O
of	O
thyroid	O
hormone	O
while	O
it	O
forms	O
a	O
complex	O
with	O
TR	B-Gene_or_gene_product
in	O
a	O
thyroid	O
hormone	O
-	O
dependent	O
manner	O
.	O

Ectopic	O
expression	O
of	O
the	O
protein	B-Gene_or_gene_product
Trip230	I-Gene_or_gene_product
in	O
cells	O
,	O
but	O
not	O
a	O
mutant	O
form	O
that	O
does	O
not	O
bind	O
to	O
TR	O
,	O
enhances	O
specifically	O
TR	B-Gene_or_gene_product
-	O
dependent	O
transcriptional	O
activity	O
.	O

Coexpression	O
of	O
wild	B-Gene_or_gene_product
-	I-Gene_or_gene_product
type	I-Gene_or_gene_product
Rb	I-Gene_or_gene_product
,	O
but	O
not	O
mutant	O
Rb	O
that	O
fails	O
to	O
bind	O
to	O
Trip230	O
,	O
inhibits	O
such	O
activity	O
.	O

These	O
results	O
not	O
only	O
identify	O
a	O
coactivator	B-Gene_or_gene_product
molecule	I-Gene_or_gene_product
that	O
modulates	O
TR	B-Gene_or_gene_product
activity	I-Gene_or_gene_product
,	O
but	O
also	O
uncover	O
a	O
role	O
for	O
Rb	B-Gene_or_gene_product
in	O
a	O
pathway	O
that	O
responds	O
to	O
thyroid	O
hormone	O
.	O

NF	O
-	O
AT	O
activation	O
induced	O
by	O
a	O
CAML	B-Gene_or_gene_product
-	I-Gene_or_gene_product
interacting	I-Gene_or_gene_product
member	I-Gene_or_gene_product
of	O
the	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
superfamily	O
.	O

Activation	O
of	O
the	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
transcription	O
factor	O
(	O
NF	O
-	O
AT	O
)	O
is	O
a	O
key	O
event	O
underlying	O
lymphocyte	O
action	O
.	O

The	O
CAML	B-Gene_or_gene_product
(	O
calcium	B-Gene_or_gene_product
-	I-Gene_or_gene_product
modulator	I-Gene_or_gene_product
and	I-Gene_or_gene_product
cyclophilin	I-Gene_or_gene_product
ligand	I-Gene_or_gene_product
)	O
protein	O
is	O
a	O
coinducer	O
of	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
AT	I-Gene_or_gene_product
activation	O
when	O
overexpressed	O
in	O
Jurkat	O
T	O
cells	O
.	O

A	O
member	O
of	O
the	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
superfamily	O
was	O
isolated	O
by	O
virtue	O
of	O
its	O
affinity	O
for	O
CAML	B-Gene_or_gene_product
.	O

Cross	O
-	O
linking	O
of	O
this	O
lymphocyte	B-Gene_or_gene_product
-	I-Gene_or_gene_product
specific	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
designated	O
TACI	B-Gene_or_gene_product
(	O
transmembrane	B-Gene_or_gene_product
activator	I-Gene_or_gene_product
and	I-Gene_or_gene_product
CAML	I-Gene_or_gene_product
-	I-Gene_or_gene_product
interactor	I-Gene_or_gene_product
)	O
,	O
on	O
the	O
surface	O
of	O
transfected	O
Jurkat	O
cells	O
with	O
TACI	B-Gene_or_gene_product
-	O
specific	O
antibodies	B-Gene_or_gene_product
led	O
to	O
activation	O
of	O
the	O
transcription	O
factors	O
NF	O
-	O
AT	O
,	O
AP	O
-	O
1	O
,	O
and	O
NFkappaB	O
.	O

TACI	B-Gene_or_gene_product
-	O
induced	O
activation	O
of	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
AT	I-Gene_or_gene_product
was	O
specifically	O
blocked	O
by	O
a	O
dominant	O
-	O
negative	O
CAML	O
mutant	O
,	O
thus	O
implicating	O
CAML	B-Gene_or_gene_product
as	O
a	O
signaling	O
intermediate	O
.	O

The	O
genomic	O
organization	O
and	O
the	O
full	O
coding	O
region	O
of	O
the	O
human	O
PAX7	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

The	O
PAX7	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
encodes	O
a	O
transcription	O
factor	O
that	O
is	O
a	O
member	O
of	O
the	O
PAX	B-Gene_or_gene_product
family	I-Gene_or_gene_product
of	O
developmental	O
control	O
genes	O
.	O

In	O
addition	O
to	O
playing	O
a	O
role	O
in	O
embryogenesis	O
,	O
PAX	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
appear	O
to	O
be	O
of	O
importance	O
in	O
a	O
number	O
of	O
diverse	O
human	O
diseases	O
and	O
cancers	O
.	O

The	O
PAX7	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
maps	O
to	O
human	O
chromosomal	O
region	O
1p36	O
and	O
therefore	O
is	O
a	O
potential	O
candidate	O
for	O
human	O
disorders	O
linked	O
to	O
this	O
region	O
.	O

In	O
particular	O
,	O
a	O
rearrangement	O
of	O
the	O
PAX7	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
by	O
chromosomal	O
translocation	O
is	O
frequently	O
found	O
in	O
alveolar	O
rhabdomyosarcoma	O
tumors	O
.	O

Here	O
,	O
we	O
cloned	O
a	O
cDNA	O
containing	O
the	O
full	O
coding	O
region	O
of	O
the	O
human	O
PAX7	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
and	O
determined	O
its	O
genomic	O
organization	O
.	O

The	O
gene	B-Gene_or_gene_product
encodes	O
a	O
predicted	O
protein	B-Gene_or_gene_product
of	O
520	O
amino	O
acids	O
that	O
is	O
47	O
amino	O
acids	O
longer	O
at	O
the	O
carboxy	O
end	O
than	O
the	O
highly	O
related	O
PAX3	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
.	O

The	O
coding	O
region	O
of	O
the	O
gene	B-Gene_or_gene_product
is	O
interrupted	O
by	O
seven	O
introns	O
,	O
the	O
positions	O
and	O
lengths	O
of	O
which	O
are	O
similar	O
to	O
those	O
of	O
the	O
corresponding	O
introns	O
of	O
the	O
PAX3	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

Sequence	O
data	O
for	O
exon	O
/	O
intron	O
boundaries	O
of	O
PAX7	B-Gene_or_gene_product
exons	O
1	O
,	O
5	O
,	O
6	O
,	O
7	O
,	O
and	O
8	O
were	O
determined	O
and	O
,	O
together	O
with	O
previously	O
published	O
data	O
for	O
exons	O
2	O
,	O
3	O
,	O
and	O
4	O
,	O
provide	O
the	O
complete	O
sequence	O
information	O
for	O
mutation	O
analysis	O
of	O
the	O
human	O
PAX7	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

The	O
homeobox	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
GBX2	B-Gene_or_gene_product
,	O
a	O
target	O
of	O
the	O
myb	B-Gene_or_gene_product
oncogene	I-Gene_or_gene_product
,	O
mediates	O
autocrine	O
growth	O
and	O
monocyte	O
differentiation	O
.	O

The	O
homeobox	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
GBX2	B-Gene_or_gene_product
was	O
identified	O
as	O
a	O
target	O
gene	B-Gene_or_gene_product
of	O
the	O
v	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Myb	I-Gene_or_gene_product
oncoprotein	I-Gene_or_gene_product
encoded	O
by	O
the	O
avian	O
myeloblastosis	O
virus	O
(	O
AMV	O
)	O
.	O

GBX2	B-Gene_or_gene_product
activation	O
by	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Myb	I-Gene_or_gene_product
requires	O
signal	O
transduction	O
emanating	O
from	O
the	O
cell	O
surface	O
while	O
the	O
leukemogenic	O
AMV	O
v	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Myb	I-Gene_or_gene_product
constitutively	O
induces	O
the	O
GBX2	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

Mutations	O
in	O
the	O
DNA	O
binding	O
domain	O
of	O
AMV	O
-	O
Myb	B-Gene_or_gene_product
render	O
it	O
independent	O
of	O
signaling	O
events	O
and	O
concomitantly	O
abrogate	O
the	O
collaboration	O
between	O
Myb	B-Gene_or_gene_product
and	O
CCAAT	B-Gene_or_gene_product
Enhancer	I-Gene_or_gene_product
Binding	I-Gene_or_gene_product
Proteins	I-Gene_or_gene_product
(	O
C	B-Gene_or_gene_product
/	I-Gene_or_gene_product
EBP	I-Gene_or_gene_product
)	O
,	O
which	O
are	O
involved	O
in	O
granulocyte	O
differentiation	O
.	O

Ectopic	O
expression	O
of	O
GBX2	B-Gene_or_gene_product
in	O
growth	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	O
dependent	O
myeloblasts	O
induces	O
monocytic	O
features	O
and	O
independence	O
from	O
exogenous	O
cytokines	B-Gene_or_gene_product
,	O
reflecting	O
distinct	O
features	O
of	O
AMV	O
-	O
transformed	O
cells	O
.	O

Our	O
results	O
suggest	O
that	O
Myb	B-Gene_or_gene_product
or	O
factors	B-Gene_or_gene_product
it	B-Gene_or_gene_product
interacts	O
with	O
contribute	O
to	O
hematopoietic	O
lineage	O
choice	O
and	O
differentiation	O
in	O
a	O
signal	O
transduction	O
-	O
dependent	O
fashion	O
.	O

Nucleolar	O
KKE	B-Gene_or_gene_product
/	I-Gene_or_gene_product
D	I-Gene_or_gene_product
repeat	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
Nop56p	B-Gene_or_gene_product
and	O
Nop58p	B-Gene_or_gene_product
interact	O
with	O
Nop1p	B-Gene_or_gene_product
and	O
are	O
required	O
for	O
ribosome	O
biogenesis	O
.	O

Different	O
point	O
mutations	O
in	O
the	O
nucleolar	O
protein	B-Gene_or_gene_product
fibrillarin	I-Gene_or_gene_product
(	O
Nop1p	B-Gene_or_gene_product
in	O
Saccharomyces	O
cerevisiae	O
)	O
can	O
inhibit	O
different	O
steps	O
in	O
ribosome	O
synthesis	O
.	O

A	O
screen	O
for	O
mutations	O
that	O
are	O
synthetically	O
lethal	O
(	O
sl	O
)	O
with	O
the	O
nop1	O
-	O
5	O
allele	O
,	O
which	O
inhibits	O
pre	O
-	O
rRNA	O
processing	O
,	O
identified	O
NOP56	B-Gene_or_gene_product
.	O

An	O
independent	O
sl	O
mutation	O
screen	O
with	O
nop1	O
-	O
3	O
,	O
which	O
inhibits	O
pre	O
-	O
rRNA	O
methylation	O
,	O
identified	O
a	O
mutation	O
in	O
NOP58	B-Gene_or_gene_product
.	O

Strikingly	O
,	O
Nop56p	B-Gene_or_gene_product
and	O
Nop58p	B-Gene_or_gene_product
are	O
highly	O
homologous	O
(	O
45	O
%	O
identity	O
)	O
.	O

Both	O
proteins	B-Gene_or_gene_product
were	O
found	O
to	O
be	O
essential	O
and	O
localized	O
to	O
the	O
nucleolus	O
.	O

A	O
temperature	O
-	O
sensitive	O
lethal	O
mutant	O
allele	O
,	O
nop56	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
inhibited	O
many	O
steps	O
in	O
pre	O
-	O
rRNA	O
processing	O
,	O
particularly	O
on	O
the	O
pathway	O
of	O
25S	O
/	O
5	O
.	O
8S	O
rRNA	O
synthesis	O
,	O
and	O
led	O
to	O
defects	O
in	O
60S	O
subunit	O
assembly	O
.	O

Epitope	O
-	O
tagged	O
constructs	O
show	O
that	O
both	O
Nop56p	B-Gene_or_gene_product
and	O
Nop58p	B-Gene_or_gene_product
are	O
associated	O
with	O
Noplp	B-Gene_or_gene_product
in	O
complexes	O
,	O
Nop56p	B-Gene_or_gene_product
and	O
Nop1p	B-Gene_or_gene_product
exhibiting	O
a	O
stoichiometric	O
association	O
.	O

These	O
physical	O
interactions	O
presumably	O
underlie	O
the	O
observed	O
sl	O
phenotypes	O
.	O

Well	O
-	O
conserved	O
homologs	B-Gene_or_gene_product
are	O
present	O
in	O
a	O
range	O
of	O
organisms	O
,	O
including	O
humans	O
(	O
52	O
%	O
identity	O
between	O
human	O
hNop56p	B-Gene_or_gene_product
and	O
yeast	O
Nop56p	B-Gene_or_gene_product
)	O
,	O
suggesting	O
that	O
these	O
complexes	O
have	O
been	O
conserved	O
in	O
evolution	O
.	O

Identification	O
of	O
multiple	O
cyclin	O
subunits	O
of	O
human	O
P	B-Gene_or_gene_product
-	I-Gene_or_gene_product
TEFb	I-Gene_or_gene_product
.	O

The	O
transition	O
from	O
abortive	O
into	O
productive	O
elongation	O
is	O
proposed	O
to	O
be	O
controlled	O
by	O
a	O
positive	B-Gene_or_gene_product
transcription	I-Gene_or_gene_product
elongation	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
b	I-Gene_or_gene_product
(	O
P	B-Gene_or_gene_product
-	I-Gene_or_gene_product
TEFb	I-Gene_or_gene_product
)	O
through	O
phosphorylation	O
of	O
the	O
carboxy	O
-	O
terminal	O
domain	O
(	O
CTD	O
)	O
of	O
the	O
largest	O
subunit	O
of	O
RNA	O
polymerase	O
II	O
.	O

Drosophila	O
P	B-Gene_or_gene_product
-	I-Gene_or_gene_product
TEFb	I-Gene_or_gene_product
was	O
identified	O
recently	O
as	O
a	O
cyclin	O
-	O
dependent	O
kinase	O
(	O
CDK9	O
)	O
paired	O
with	O
a	O
cyclin	B-Gene_or_gene_product
subunit	O
(	O
cyclin	O
T	O
)	O
.	O

We	O
demonstrate	O
here	O
the	O
cloning	O
of	O
multiple	O
cyclin	O
subunits	O
of	O
human	O
P	B-Gene_or_gene_product
-	I-Gene_or_gene_product
TEFb	I-Gene_or_gene_product
(	O
T1	O
and	O
T2	O
)	O
.	O

Cyclin	O
T2	O
has	O
two	O
forms	O
(	O
T2a	O
and	O
T2b	O
)	O
because	O
of	O
alternative	O
splicing	O
.	O

Both	O
cyclin	O
T1	O
and	O
T2	O
are	O
ubiquitously	O
expressed	O
.	O

Immunoprecipitation	O
and	O
immunodepletion	O
experiments	O
carried	O
out	O
on	O
HeLa	O
nuclear	O
extract	O
(	O
HNE	O
)	O
indicated	O
that	O
cyclin	O
T1	O
and	O
T2	O
were	O
associated	O
with	O
CDK9	O
in	O
a	O
mutually	O
exclusive	O
manner	O
and	O
that	O
almost	O
all	O
CDK9	O
was	O
associated	O
with	O
either	O
cyclin	O
T1	O
or	O
T2	O
.	O

Recombinant	O
CDK9	O
/	O
cyclin	O
T1	O
,	O
CDK9	O
/	O
cyclin	O
T2a	O
,	O
and	O
CDK9	O
/	O
cyclin	O
T2b	O
produced	O
in	O
Sf9	O
cells	O
possessed	O
DRB	O
-	O
sensitive	O
kinase	O
activity	O
and	O
functioned	O
in	O
transcription	O
elongation	O
in	O
vitro	O
.	O

Either	O
cyclin	O
T1	O
or	O
T2	O
was	O
required	O
to	O
activate	O
CDK9	O
,	O
and	O
the	O
truncation	O
of	O
the	O
carboxyl	O
terminus	O
of	O
the	O
cyclin	B-Gene_or_gene_product
reduced	O
,	O
but	O
did	O
not	O
eliminate	O
,	O
P	B-Gene_or_gene_product
-	I-Gene_or_gene_product
TEFb	I-Gene_or_gene_product
activity	O
.	O

Cotransfection	O
experiments	O
indicated	O
that	O
all	O
three	O
CDK9	O
/	O
cyclin	O
combinations	O
dramatically	O
activated	O
the	O
CMV	O
promoter	O
.	O

E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
,	O
a	O
member	O
of	O
the	O
E2F	B-Gene_or_gene_product
family	I-Gene_or_gene_product
that	O
can	O
behave	O
as	O
a	O
transcriptional	O
repressor	O
.	O

The	O
E2F	B-Gene_or_gene_product
family	I-Gene_or_gene_product
of	O
proteins	B-Gene_or_gene_product
is	O
required	O
to	O
establish	O
the	O
correct	O
cell	O
-	O
cycle	O
-	O
dependent	O
transcription	O
of	O
genes	B-Gene_or_gene_product
that	O
direct	O
the	O
process	O
of	O
cell	O
division	O
.	O

All	O
previously	O
identified	O
E2F	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
can	O
act	O
in	O
a	O
similar	O
manner	O
;	O
depending	O
on	O
whether	O
or	O
not	O
they	O
are	O
associated	O
with	O
the	O
cell	O
cycle	O
inhibitors	O
the	O
retinoblastoma	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
pRB	B-Gene_or_gene_product
)	O
,	O
p107	B-Gene_or_gene_product
,	O
or	O
p130	B-Gene_or_gene_product
,	O
they	O
can	O
either	O
repress	O
or	O
activate	O
the	O
transcription	O
of	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
responsive	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
.	O

We	O
now	O
report	O
the	O
cloning	O
and	O
characterization	O
of	O
another	O
E2F	B-Gene_or_gene_product
family	I-Gene_or_gene_product
member	I-Gene_or_gene_product
,	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
,	O
whose	O
structure	O
is	O
reminiscent	O
of	O
the	O
dominant	O
inhibitors	O
of	O
other	O
transcription	O
factor	O
families	O
.	O

The	O
dimerization	O
and	O
DNA	O
binding	O
properties	O
of	O
E2F	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
are	O
similar	O
to	O
those	O
of	O
the	O
other	O
E2F	B-Gene_or_gene_product
family	I-Gene_or_gene_product
members	I-Gene_or_gene_product
.	O

However	O
,	O
it	O
is	O
not	O
regulated	O
by	O
pRB	O
,	O
p107	O
,	O
or	O
p130	O
,	O
and	O
it	O
is	O
unable	O
to	O
activate	O
transcription	O
.	O

Instead	O
,	O
it	B-Gene_or_gene_product
can	O
act	O
to	O
repress	O
the	O
transcription	O
of	O
E2F	B-Gene_or_gene_product
responsive	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
by	O
countering	O
the	O
activity	O
of	O
the	O
other	O
E2F	O
complexes	O
via	O
a	O
pRB	B-Gene_or_gene_product
-	O
,	O
p107	B-Gene_or_gene_product
-	O
,	O
or	O
p130	B-Gene_or_gene_product
-	O
independent	O
mechanism	O
.	O

Isolation	O
and	O
expression	O
of	O
a	O
human	O
SRY	O
-	O
related	O
cDNA	O
hSOX20	B-Gene_or_gene_product
.	O

SOX	B-Gene_or_gene_product
is	O
a	O
family	O
of	O
genes	B-Gene_or_gene_product
related	O
to	O
the	O
testis	B-Gene_or_gene_product
-	I-Gene_or_gene_product
determining	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
,	O
SRY	B-Gene_or_gene_product
.	O

We	O
have	O
isolated	O
and	O
sequenced	O
an	O
hSOX20	B-Gene_or_gene_product
cDNA	O
from	O
a	O
cell	O
line	O
of	O
human	O
embryonic	O
carcinoma	O
.	O

This	O
cDNA	O
contains	O
an	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
encoding	O
233	O
amino	O
acids	O
.	O

The	O
protein	B-Gene_or_gene_product
encompasses	O
an	O
SRY	B-Gene_or_gene_product
-	O
type	O
HMG	O
box	O
exhibiting	O
strong	O
homologies	O
to	O
those	O
of	O
mouse	O
Sox15	B-Gene_or_gene_product
and	O
Sox16	B-Gene_or_gene_product
.	O

Various	O
adult	O
and	O
fetal	O
tissues	O
were	O
tested	O
for	O
hSOX20	B-Gene_or_gene_product
mRNA	O
by	O
Northern	O
analysis	O
.	O

Its	O
expression	O
is	O
restricted	O
to	O
the	O
fetal	O
testis	O
and	O
the	O
size	O
of	O
the	O
transcript	O
is	O
1	O
.	O
5	O
knt	O
.	O

Electrophoretic	O
mobility	O
shift	O
assay	O
indicated	O
that	O
recombinant	O
hSOX20	B-Gene_or_gene_product
polypeptide	O
is	O
capable	O
of	O
binding	O
to	O
AACAAT	O
sequence	O
.	O

Oxidized	B-Gene_or_gene_product
LDL	I-Gene_or_gene_product
regulates	O
macrophage	O
gene	O
expression	O
through	O
ligand	O
activation	O
of	O
PPARgamma	B-Gene_or_gene_product
.	O

Macrophage	O
uptake	O
of	O
oxidized	B-Gene_or_gene_product
low	I-Gene_or_gene_product
-	I-Gene_or_gene_product
density	I-Gene_or_gene_product
lipoprotein	I-Gene_or_gene_product
(	O
oxLDL	B-Gene_or_gene_product
)	O
is	O
thought	O
to	O
play	O
a	O
central	O
role	O
in	O
foam	O
cell	O
formation	O
and	O
the	O
pathogenesis	O
of	O
atherosclerosis	O
.	O

We	O
demonstrate	O
here	O
that	O
oxLDL	B-Gene_or_gene_product
activates	O
PPARgamma	B-Gene_or_gene_product
-	O
dependent	O
transcription	O
through	O
a	O
novel	O
signaling	O
pathway	O
involving	O
scavenger	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	O
mediated	O
particle	O
uptake	O
.	O

Moreover	O
,	O
we	O
identify	O
two	O
of	O
the	O
major	O
oxidized	O
lipid	O
components	O
of	O
oxLDL	B-Gene_or_gene_product
,	O
9	O
-	O
HODE	O
and	O
13	O
-	O
HODE	O
,	O
as	O
endogenous	O
activators	O
and	O
ligands	O
of	O
PPARgamma	B-Gene_or_gene_product
.	O

Our	O
data	O
suggest	O
that	O
the	O
biologic	O
effects	O
of	O
oxLDL	B-Gene_or_gene_product
are	O
coordinated	O
by	O
two	O
sets	O
of	O
receptors	B-Gene_or_gene_product
,	O
one	O
on	O
the	O
cell	O
surface	O
,	O
which	O
binds	O
and	O
internalizes	O
the	O
particle	O
,	O
and	O
one	O
in	O
the	O
nucleus	O
,	O
which	O
is	O
transcriptionally	O
activated	O
by	O
its	O
component	O
lipids	O
.	O

These	O
results	O
suggest	O
that	O
PPARgamma	B-Gene_or_gene_product
may	O
be	O
a	O
key	O
regulator	O
of	O
foam	O
cell	O
gene	O
expression	O
.	O

A	O
stress	O
response	O
pathway	O
from	O
the	O
endoplasmic	O
reticulum	O
to	O
the	O
nucleus	O
requires	O
a	O
novel	O
bifunctional	O
protein	O
kinase	O
/	O
endoribonuclease	O
(	O
Ire1p	B-Gene_or_gene_product
)	O
in	O
mammalian	O
cells	O
.	O

Eukaryotes	O
respond	O
to	O
the	O
presence	O
of	O
unfolded	O
protein	B-Gene_or_gene_product
in	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
by	O
up	O
-	O
regulating	O
the	O
transcription	O
of	O
genes	B-Gene_or_gene_product
encoding	O
ER	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
chaperones	I-Gene_or_gene_product
,	O
such	O
as	O
BiP	B-Gene_or_gene_product
.	O

We	O
have	O
isolated	O
a	O
novel	O
human	O
cDNA	O
encoding	O
a	O
homolog	B-Gene_or_gene_product
to	O
Saccharomyces	O
cerevisiae	O
Ire1p	B-Gene_or_gene_product
,	O
a	O
proximal	O
sensor	O
for	O
this	O
signal	O
transduction	O
pathway	O
in	O
yeast	O
.	O

The	O
gene	O
product	O
hIre1p	O
is	O
a	O
type	B-Gene_or_gene_product
1	I-Gene_or_gene_product
transmembrane	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
containing	O
a	O
cytoplasmic	O
domain	O
that	O
is	O
highly	O
conserved	O
to	O
the	O
yeast	O
counterpart	B-Gene_or_gene_product
having	O
a	O
Ser	O
/	O
Thr	O
protein	O
kinase	O
domain	O
and	O
a	O
domain	O
homologous	O
to	O
RNase	O
L	O
.	O

However	O
,	O
the	O
luminal	O
domain	O
has	O
extensively	O
diverged	O
from	O
the	O
yeast	O
gene	O
product	O
.	O

hIre1p	B-Gene_or_gene_product
expressed	O
in	O
mammalian	O
cells	O
displayed	O
intrinsic	O
autophosphorylation	O
activity	O
and	O
an	O
endoribonuclease	O
activity	O
that	O
cleaved	O
the	O
5	O
'	O
splice	O
site	O
of	O
yeast	O
HAC1	B-Gene_or_gene_product
mRNA	O
,	O
a	O
substrate	O
for	O
the	O
endoribonuclease	O
activity	O
of	O
yeast	O
Ire1p	B-Gene_or_gene_product
.	O

Overexpressed	O
hIre1p	B-Gene_or_gene_product
was	O
localized	O
to	O
the	O
ER	O
with	O
particular	O
concentration	O
around	O
the	O
nuclear	O
envelope	O
and	O
some	O
colocalization	O
with	O
the	O
nuclear	O
pore	O
complex	O
.	O

Expression	O
of	O
Ire1p	O
mRNA	O
was	O
autoregulated	O
through	O
a	O
process	O
that	O
required	O
a	O
functional	O
hIre1p	B-Gene_or_gene_product
kinase	O
activity	O
.	O

Finally	O
,	O
overexpression	O
of	O
wild	B-Gene_or_gene_product
-	I-Gene_or_gene_product
type	I-Gene_or_gene_product
hIre1p	I-Gene_or_gene_product
constitutively	O
activated	O
a	O
reporter	O
gene	O
under	O
transcriptional	O
control	O
of	O
the	O
rat	O
BiP	B-Gene_or_gene_product
promoter	O
,	O
whereas	O
expression	O
of	O
a	O
catalytically	O
inactive	O
hIre1p	B-Gene_or_gene_product
acted	O
in	O
a	O
trans	O
-	O
dominant	O
-	O
negative	O
manner	O
to	O
prevent	O
transcriptional	O
activation	O
of	O
the	O
BiP	B-Gene_or_gene_product
promoter	O
in	O
response	O
to	O
ER	O
stress	O
induced	O
by	O
inhibition	O
of	O
N	O
-	O
linked	O
glycosylation	O
.	O

These	O
results	O
demonstrate	O
that	O
hIre1p	B-Gene_or_gene_product
is	O
an	O
essential	O
proximal	O
sensor	O
of	O
the	O
unfolded	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
response	O
pathway	O
in	O
mammalian	O
cells	O
.	O

Identification	O
of	O
a	O
novel	O
isoform	O
of	O
microphthalmia	O
-	O
associated	O
transcription	O
factor	O
that	O
is	O
enriched	O
in	O
retinal	O
pigment	O
epithelium	O
.	O

Mutations	O
at	O
the	O
mouse	O
locus	O
encoding	O
microphthalmia	O
-	O
associated	O
transcription	O
factor	O
(	O
Mitf	O
)	O
affect	O
the	O
development	O
of	O
many	O
cell	O
types	O
,	O
including	O
retinal	O
pigment	O
epithelium	O
(	O
RPE	O
)	O
,	O
melanocytes	O
,	O
mast	O
cells	O
,	O
and	O
osteoclasts	O
.	O

Here	O
we	O
have	O
identified	O
a	O
novel	O
Mitf	O
isoform	O
,	O
Mitf	B-Gene_or_gene_product
-	I-Gene_or_gene_product
a	I-Gene_or_gene_product
,	O
and	O
its	O
human	O
homologue	O
MITF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
A	I-Gene_or_gene_product
by	O
cDNA	O
cloning	O
.	O

MITF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
A	I-Gene_or_gene_product
consists	O
of	O
520	O
amino	O
acid	O
residues	O
and	O
differs	O
in	O
the	O
amino	O
-	O
terminus	O
from	O
authentic	O
melanocyte	B-Gene_or_gene_product
-	I-Gene_or_gene_product
type	I-Gene_or_gene_product
MITF	I-Gene_or_gene_product
(	O
MITF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
M	I-Gene_or_gene_product
)	O
.	O

MITF	O
-	O
A	O
mRNA	O
is	O
widely	O
expressed	O
and	O
represents	O
a	O
predominant	O
MITF	B-Gene_or_gene_product
isoform	O
in	O
cultured	O
RPE	O
cells	O
,	O
whereas	O
MITF	O
-	O
M	O
mRNA	O
is	O
exclusively	O
expressed	O
in	O
melanocytes	O
and	O
melanoma	O
cells	O
.	O

In	O
situ	O
hybridization	O
analysis	O
suggested	O
that	O
Mitf	O
-	O
a	O
mRNA	O
is	O
enriched	O
in	O
the	O
prospective	O
RPE	O
of	O
mouse	O
embryo	O
.	O

Moreover	O
,	O
transient	O
cotransfection	O
assays	O
suggested	O
that	O
MITF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
A	I-Gene_or_gene_product
activated	O
transcription	O
of	O
the	O
tyrosinase	B-Gene_or_gene_product
and	I-Gene_or_gene_product
tyrosinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
related	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
1	I-Gene_or_gene_product
genes	I-Gene_or_gene_product
.	O

MITF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
A	I-Gene_or_gene_product
/	I-Gene_or_gene_product
Mitf	I-Gene_or_gene_product
-	I-Gene_or_gene_product
a	I-Gene_or_gene_product
therefore	O
may	O
play	O
an	O
important	O
role	O
in	O
melanogenesis	O
in	O
RPE	O
.	O

Mitogen	O
-	O
and	O
stress	O
-	O
activated	O
protein	O
kinase	O
-	O
1	O
(	O
MSK1	O
)	O
is	O
directly	O
activated	O
by	O
MAPK	O
and	O
SAPK2	O
/	O
p38	O
,	O
and	O
may	O
mediate	O
activation	O
of	O
CREB	B-Gene_or_gene_product
.	O

We	O
have	O
identified	O
a	O
novel	O
mitogen	O
-	O
and	O
stress	O
-	O
activated	O
protein	O
kinase	O
(	O
MSK1	O
)	O
that	O
contains	O
two	O
protein	O
kinase	O
domains	O
in	O
a	O
single	O
polypeptide	O
.	O

MSK1	O
is	O
activated	O
in	O
vitro	O
by	O
MAPK2	O
/	O
ERK2	O
or	O
SAPK2	O
/	O
p38	O
.	O

Endogenous	O
MSK1	O
is	O
activated	O
in	O
293	O
cells	O
by	O
either	O
growth	O
factor	O
/	O
phorbol	O
ester	O
stimulation	O
,	O
or	O
by	O
exposure	O
to	O
UV	O
radiation	O
,	O
and	O
oxidative	O
and	O
chemical	O
stress	O
.	O

The	O
activation	O
of	O
MSK1	O
by	O
growth	O
factors	O
/	O
phorbol	O
esters	O
is	O
prevented	O
by	O
PD	O
98059	O
,	O
which	O
suppresses	O
activation	O
of	O
the	O
MAPK	O
cascade	O
,	O
while	O
the	O
activation	O
of	O
MSK1	O
by	O
stress	O
stimuli	O
is	O
prevented	O
by	O
SB	O
203580	O
,	O
a	O
specific	O
inhibitor	O
of	O
SAPK2	O
/	O
p38	O
.	O

In	O
HeLa	O
,	O
PC12	O
and	O
SK	O
-	O
N	O
-	O
MC	O
cells	O
,	O
PD	O
98059	O
and	O
SB	O
203580	O
are	O
both	O
required	O
to	O
suppress	O
the	O
activation	O
of	O
MSK1	O
by	O
TNF	B-Gene_or_gene_product
,	O
NGF	B-Gene_or_gene_product
and	O
FGF	B-Gene_or_gene_product
,	O
respectively	O
,	O
because	O
these	O
agonists	O
activate	O
both	O
the	O
MAPK	O
/	O
ERK	O
and	O
SAPK2	O
/	O
p38	O
cascades	O
.	O

MSK1	O
is	O
localized	O
in	O
the	O
nucleus	O
of	O
unstimulated	O
or	O
stimulated	O
cells	O
,	O
and	O
phosphorylates	O
CREB	B-Gene_or_gene_product
at	O
Ser133	O
with	O
a	O
Km	O
value	O
far	O
lower	O
than	O
PKA	O
,	O
MAPKAP	O
-	O
K1	O
(	O
p90Rsk	O
)	O
and	O
MAPKAP	O
-	O
K2	O
.	O

The	O
effects	O
of	O
SB	O
203580	O
,	O
PD	O
98059	O
and	O
Ro	O
318220	O
on	O
agonist	O
-	O
induced	O
activation	O
of	O
CREB	B-Gene_or_gene_product
and	O
ATF1	B-Gene_or_gene_product
in	O
four	O
cell	O
-	O
lines	O
mirror	O
the	O
effects	O
of	O
these	B-Gene_or_gene_product
inhibitors	I-Gene_or_gene_product
on	O
MSK1	O
activation	O
,	O
and	O
exclude	O
a	O
role	O
for	O
MAPKAP	O
-	O
K1	O
and	O
MAPKAP	O
-	O
K2	O
/	O
3	O
in	O
this	O
process	O
.	O

These	O
findings	O
,	O
together	O
with	O
other	O
observations	O
,	O
suggest	O
that	O
MSK1	O
may	O
mediate	O
the	O
growth	B-Gene_or_gene_product
-	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
and	O
stress	O
-	O
induced	O
activation	O
of	O
CREB	B-Gene_or_gene_product
.	O

Identification	O
of	O
a	O
novel	O
RING	B-Gene_or_gene_product
finger	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
as	O
a	O
coregulator	O
in	O
steroid	O
receptor	O
-	O
mediated	O
gene	B-Gene_or_gene_product
transcription	O
.	O

Using	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
androgen	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	O
AR	B-Gene_or_gene_product
)	O
as	O
a	O
bait	O
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
screening	O
,	O
we	O
have	O
identified	O
a	O
small	O
nuclear	O
RING	B-Gene_or_gene_product
finger	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
termed	O
SNURF	B-Gene_or_gene_product
,	O
that	O
interacts	O
with	O
AR	B-Gene_or_gene_product
in	O
a	O
hormone	O
-	O
dependent	O
fashion	O
in	O
both	O
yeast	O
and	O
mammalian	O
cells	O
.	O

Physical	O
interaction	O
between	O
AR	B-Gene_or_gene_product
and	O
SNURF	B-Gene_or_gene_product
was	O
demonstrated	O
by	O
coimmunoprecipitation	O
from	O
cell	O
extracts	O
and	O
by	O
protein	O
-	O
protein	O
affinity	O
chromatography	O
.	O

Rat	O
SNURF	B-Gene_or_gene_product
is	O
a	O
highly	O
hydrophilic	O
protein	B-Gene_or_gene_product
consisting	O
of	O
194	O
amino	O
acid	O
residues	O
and	O
comprising	O
a	O
consensus	O
C3HC4	O
zinc	O
finger	O
(	O
RING	O
)	O
structure	O
in	O
the	O
C	O
-	O
terminal	O
region	O
and	O
a	O
bipartite	O
nuclear	O
localization	O
signal	O
near	O
the	O
N	O
terminus	O
.	O

Immunohistochemical	O
experiments	O
indicated	O
that	O
SNURF	B-Gene_or_gene_product
is	O
a	O
nuclear	O
protein	B-Gene_or_gene_product
.	O

SNURF	B-Gene_or_gene_product
mRNA	O
is	O
expressed	O
in	O
a	O
variety	O
of	O
human	O
and	O
rat	O
tissues	O
.	O

Overexpression	O
of	O
SNURF	B-Gene_or_gene_product
in	O
cultured	O
mammalian	O
cells	O
enhanced	O
not	O
only	O
androgen	O
,	O
glucocorticoid	O
,	O
and	O
progesterone	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	O
dependent	O
transactivation	O
but	O
also	O
basal	O
transcription	O
from	O
steroid	O
-	O
regulated	O
promoters	O
.	O

Mutation	O
of	O
two	O
of	O
the	O
potential	O
Zn2	O
+	O
coordinating	O
cysteines	O
to	O
serines	O
in	O
the	O
RING	O
finger	O
completely	O
abolished	O
the	O
ability	O
of	O
SNURF	B-Gene_or_gene_product
to	O
enhance	O
basal	O
transcription	O
,	O
whereas	O
its	O
ability	O
to	O
activate	O
steroid	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	O
dependent	O
transcription	O
was	O
maintained	O
,	O
suggesting	O
that	O
there	O
are	O
separate	O
domains	O
in	O
SNURF	B-Gene_or_gene_product
that	O
mediate	O
interactions	O
with	O
different	O
regulatory	B-Gene_or_gene_product
factors	I-Gene_or_gene_product
.	O

SNURF	B-Gene_or_gene_product
is	O
capable	O
of	O
interacting	O
in	O
vitro	O
with	O
the	O
TATA	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
and	O
the	O
RING	O
finger	O
domain	O
is	O
needed	O
for	O
this	O
interaction	O
.	O

Collectively	O
,	O
we	O
have	O
identified	O
and	O
characterized	O
a	O
ubiquitously	O
expressed	O
RING	B-Gene_or_gene_product
finger	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
SNURF	B-Gene_or_gene_product
,	O
that	O
may	O
function	O
as	O
a	O
bridging	O
factor	O
and	O
regulate	O
steroid	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
-	O
dependent	O
transcription	O
by	O
a	O
mechanism	O
different	O
from	O
those	O
of	O
previously	O
identified	O
coactivator	O
or	O
integrator	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

The	O
human	O
forkhead	O
protein	O
FREAC	O
-	O
2	O
contains	O
two	O
functionally	O
redundant	O
activation	O
domains	O
and	O
interacts	O
with	O
TBP	B-Gene_or_gene_product
and	O
TFIIB	B-Gene_or_gene_product
.	O

Forkhead	O
-	O
related	O
activator	O
2	O
(	O
FREAC	O
-	O
2	O
)	O
is	O
a	O
human	O
transcription	O
factor	O
expressed	O
in	O
lung	O
and	O
placenta	O
that	O
binds	O
to	O
cis	O
-	O
elements	O
in	O
several	O
lung	O
-	O
specific	O
genes	B-Gene_or_gene_product
.	O

We	O
have	O
identified	O
the	O
parts	O
of	O
FREAC	O
-	O
2	O
responsible	O
for	O
trans	O
-	O
activation	O
and	O
found	O
two	O
functionally	O
redundant	O
activation	O
domains	O
on	O
the	O
C	O
-	O
terminal	O
side	O
of	O
the	O
DNA	O
binding	O
forkhead	O
domain	O
.	O

Activation	O
domain	O
1	O
consists	O
of	O
the	O
most	O
C	O
-	O
terminal	O
23	O
amino	O
acids	O
of	O
FREAC	O
-	O
2	O
and	O
contains	O
a	O
sequence	O
motif	O
conserved	O
in	O
an	O
activation	O
domain	O
of	O
another	O
forkhead	O
protein	O
,	O
FREAC	O
-	O
1	O
.	O

Activation	O
domain	O
2	O
is	O
built	O
up	O
by	O
three	O
synergistic	O
subdomains	O
in	O
the	O
central	O
part	O
of	O
the	O
FREAC	O
-	O
2	O
protein	O
.	O

FREAC	O
-	O
2	O
was	O
shown	O
to	O
interact	O
in	O
vitro	O
with	O
TBP	B-Gene_or_gene_product
and	O
TFIIB	B-Gene_or_gene_product
.	O

The	O
target	O
site	O
for	O
FREAC	O
-	O
2	O
on	O
TBP	B-Gene_or_gene_product
was	O
localized	O
to	O
the	O
N	O
-	O
terminal	O
repeat	O
in	O
the	O
core	O
domain	O
of	O
TBP	B-Gene_or_gene_product
.	O

TFIIB	B-Gene_or_gene_product
binds	O
FREAC	O
-	O
2	O
close	O
to	O
the	O
cleft	O
between	O
its	O
two	O
globular	O
domains	O
.	O

The	O
part	O
of	O
FREAC	O
-	O
2	O
that	O
binds	O
TBP	B-Gene_or_gene_product
was	O
mapped	O
to	O
21	O
amino	O
acids	O
in	O
the	O
C	O
-	O
terminal	O
end	O
of	O
the	O
forkhead	O
domain	O
.	O

This	O
sequence	O
is	O
well	O
conserved	O
among	O
forkhead	O
proteins	O
,	O
raising	O
the	O
possibility	O
that	O
interaction	O
with	O
TBP	B-Gene_or_gene_product
may	O
be	O
a	O
general	O
characteristic	O
of	O
this	O
family	O
of	O
transcription	O
factors	O
.	O

Overexpression	O
of	O
TFIIB	B-Gene_or_gene_product
potentiates	O
activation	O
by	O
FREAC	O
-	O
2	O
in	O
a	O
manner	O
dependent	O
on	O
the	O
FREAC	O
-	O
2	O
activation	O
domains	O
.	O

Nuclear	O
localization	O
of	O
FREAC	O
-	O
2	O
was	O
found	O
to	O
depend	O
on	O
sequences	O
from	O
both	O
ends	O
of	O
the	O
forkhead	O
domain	O
.	O

Cloning	O
and	O
mapping	O
of	O
SMARCA5	B-Gene_or_gene_product
encoding	O
hSNF2H	B-Gene_or_gene_product
,	O
a	O
novel	O
human	O
homologue	O
of	O
Drosophila	O
ISWI	B-Gene_or_gene_product
.	O

We	O
have	O
isolated	O
a	O
novel	O
cDNA	O
encoding	O
a	O
peptide	O
with	O
86	O
%	O
sequence	O
homology	O
to	O
hSNF2L	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
,	O
a	O
previously	O
isolated	O
human	O
homologue	O
of	O
Drosophila	O
ISWI	B-Gene_or_gene_product
.	O

This	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
,	O
designated	O
SMARCA5	B-Gene_or_gene_product
,	O
contained	O
an	O
open	O
reading	O
frame	O
of	O
3	O
,	O
156	O
nucleotides	O
encoding	O
a	O
1	O
,	O
052	O
amino	O
-	O
acid	O
peptide	O
(	O
hSNF2H	B-Gene_or_gene_product
)	O
.	O

As	O
this	O
product	O
also	O
revealed	O
a	O
significant	O
(	O
73	O
%	O
)	O
identity	O
in	O
amino	O
acid	O
sequence	O
to	O
ISWI	B-Gene_or_gene_product
,	O
a	O
key	O
component	O
of	O
chromatin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
remodeling	I-Gene_or_gene_product
factors	I-Gene_or_gene_product
in	O
Drosophila	O
,	O
hSNF2H	B-Gene_or_gene_product
may	O
be	O
another	O
human	O
homologue	O
of	O
this	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
and	O
,	O
as	O
such	O
,	O
could	O
be	O
involved	O
in	O
chromatin	O
remodeling	O
in	O
humans	O
.	O

An	O
ATPase	O
domain	O
characteristic	O
of	O
the	O
SWI2	B-Gene_or_gene_product
/	I-Gene_or_gene_product
SNF2	I-Gene_or_gene_product
family	I-Gene_or_gene_product
of	O
proteins	B-Gene_or_gene_product
was	O
highly	O
conserved	O
in	O
ISWI	B-Gene_or_gene_product
,	O
hSNF2L	B-Gene_or_gene_product
,	O
and	O
hSNF2H	B-Gene_or_gene_product
.	O

Northern	O
-	O
blot	O
analysis	O
demonstrated	O
ubiquitous	O
expression	O
of	O
5	O
.	O
1	O
-	O
kb	O
and	O
4	O
.	O
1	O
-	O
kb	O
transcripts	O
of	O
the	O
hSNF2H	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

This	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
was	O
mapped	O
by	O
FISH	O
to	O
chromosome	O
bands	O
4q31	O
.	O
1	O
-	O
-	O
>	O
q31	O
.	O
2	O
.	O

The	O
PEBP2betaMYH11	O
fusion	O
created	O
by	O
Inv	O
(	O
16	O
)	O
(	O
p13	O
;	O
q22	O
)	O
in	O
myeloid	O
leukemia	O
impairs	O
neutrophil	O
maturation	O
and	O
contributes	O
to	O
granulocytic	O
dysplasia	O
.	O

Chromosomal	O
translocations	O
involving	O
the	O
genes	B-Gene_or_gene_product
encoding	O
the	O
alpha	O
and	O
beta	O
subunits	O
of	O
the	O
Pebp2	O
/	O
Cbf	O
transcription	O
factor	O
have	O
been	O
associated	O
with	O
human	O
acute	O
myeloid	O
leukemia	O
and	O
the	O
preleukemic	O
condition	O
,	O
myelodysplasia	O
.	O

Inv	O
(	O
16	O
)	O
(	O
p13	O
;	O
q22	O
)	O
fuses	O
the	O
gene	B-Gene_or_gene_product
encoding	O
the	O
beta	O
subunit	O
of	O
Pebp2	B-Gene_or_gene_product
to	O
the	O
MYH11	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
encoding	O
a	O
smooth	B-Gene_or_gene_product
muscle	I-Gene_or_gene_product
myosin	I-Gene_or_gene_product
heavy	I-Gene_or_gene_product
chain	I-Gene_or_gene_product
(	O
Smmhc	B-Gene_or_gene_product
)	O
.	O

To	O
examine	O
the	O
effect	O
of	O
the	O
inv	O
(	O
16	O
)	O
(	O
p13	O
;	O
q22	O
)	O
on	O
myelopoiesis	O
,	O
we	O
used	O
the	O
hMRP8	O
promoter	O
element	O
to	O
generate	O
transgenic	O
mice	O
expressing	O
the	O
Pebp2betaSmmhc	O
chimeric	O
fusion	O
protein	O
in	O
myeloid	O
cells	O
.	O

Neutrophil	O
maturation	O
was	O
impaired	O
in	O
PEBP2betaMYH11	O
transgenic	O
mice	O
.	O

Although	O
the	O
transgenic	O
mice	O
had	O
normal	O
numbers	O
of	O
circulating	O
neutrophils	O
,	O
their	O
bone	O
marrow	O
contained	O
increased	O
numbers	O
of	O
immature	O
neutrophilic	O
cells	O
,	O
which	O
exhibited	O
abnormal	O
characteristics	O
.	O

In	O
addition	O
,	O
PEBP2betaMYH11	O
inhibited	O
neutrophilic	O
differentiation	O
in	O
colonies	O
derived	O
from	O
hematopoietic	O
progenitors	O
.	O

Coexpression	O
of	O
both	O
PEBP2betaMYH11	O
and	O
activated	O
NRAS	B-Gene_or_gene_product
induced	O
a	O
more	O
severe	O
phenotype	O
characterized	O
by	O
abnormal	O
nuclear	O
morphology	O
indicative	O
of	O
granulocytic	O
dysplasia	O
.	O

These	O
results	O
show	O
that	O
PEBP2betaMYH11	O
can	O
impair	O
neutrophil	O
development	O
and	O
provide	O
evidence	O
that	O
alterations	O
of	O
Pebp2	B-Gene_or_gene_product
can	O
contribute	O
to	O
the	O
genesis	O
of	O
myelodysplasia	O
.	O

A	O
SWI	O
/	O
SNF	O
-	O
related	O
chromatin	O
remodeling	O
complex	O
,	O
E	O
-	O
RC1	O
,	O
is	O
required	O
for	O
tissue	O
-	O
specific	O
transcriptional	O
regulation	O
by	O
EKLF	B-Gene_or_gene_product
in	O
vitro	O
.	O

Erythroid	B-Gene_or_gene_product
Krueppel	I-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
EKLF	B-Gene_or_gene_product
)	O
is	O
necessary	O
for	O
stage	O
-	O
specific	O
expression	O
of	O
the	O
human	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
globin	I-Gene_or_gene_product
gene	I-Gene_or_gene_product
.	O

We	O
show	O
that	O
EKLF	B-Gene_or_gene_product
requires	O
a	O
SWI	O
/	O
SNF	O
-	O
related	O
chromatin	O
remodeling	O
complex	O
,	O
EKLF	O
coactivator	O
-	O
remodeling	O
complex	O
1	O
(	O
E	O
-	O
RC1	O
)	O
,	O
to	O
generate	O
a	O
DNase	O
I	O
hypersensitive	O
,	O
transcriptionally	O
active	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
globin	I-Gene_or_gene_product
promoter	O
on	O
chromatin	O
templates	O
in	O
vitro	O
.	O

E	O
-	O
RC1	O
contains	O
BRG1	O
,	O
BAF170	O
,	O
BAF155	O
,	O
and	O
INI1	O
(	O
BAF47	O
)	O
homologs	O
of	O
yeast	O
SWI	O
/	O
SNF	O
subunits	O
,	O
as	O
well	O
as	O
a	O
subunit	O
unique	O
to	O
higher	O
eukaryotes	O
,	O
BAF57	O
,	O
which	O
is	O
critical	O
for	O
chromatin	O
remodeling	O
and	O
transcription	O
with	O
EKLF	B-Gene_or_gene_product
.	O

E	O
-	O
RC1	O
displays	O
functional	O
selectivity	O
toward	O
transcription	O
factors	O
,	O
since	O
it	O
cannot	O
activate	O
expression	O
of	O
chromatin	O
-	O
assembled	O
HIV	O
-	O
1	O
templates	O
with	O
the	O
E	O
box	O
-	O
binding	O
protein	O
TFE	O
-	O
3	O
.	O

Thus	O
,	O
a	O
member	O
of	O
the	O
SWI	O
/	O
SNF	O
family	O
acts	O
directly	O
in	O
transcriptional	O
activation	O
and	O
may	O
regulate	O
subsets	O
of	O
genes	B-Gene_or_gene_product
by	O
selectively	O
interacting	O
with	O
specific	O
DNA	B-Gene_or_gene_product
-	I-Gene_or_gene_product
binding	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

Characterization	O
of	O
a	O
human	O
homologue	O
of	O
the	O
Saccharomyces	O
cerevisiae	O
transcription	O
factor	O
spt3	O
(	O
SUPT3H	O
)	O
.	O

Spt3	O
is	O
a	O
Saccharomyces	O
cerevisiae	O
transcription	O
factor	O
that	O
is	O
required	O
in	O
vivo	O
for	O
the	O
transcription	O
of	O
a	O
number	O
of	O
RNA	O
polymerase	O
II	O
-	O
transcribed	O
genes	B-Gene_or_gene_product
.	O

We	O
report	O
the	O
cloning	O
of	O
the	O
gene	B-Gene_or_gene_product
encoding	O
the	O
human	O
homologue	O
of	O
Spt3	O
,	O
SUPT3H	O
,	O
and	O
its	O
initial	O
functional	O
analysis	O
.	O

The	O
human	O
and	O
yeast	O
Spt3	O
homologues	O
share	O
an	O
overall	O
identity	O
of	O
30	O
%	O
that	O
defines	O
three	O
conserved	O
regions	O
,	O
suggesting	O
possible	O
functional	O
domains	O
.	O

To	O
determine	O
whether	O
SUPT3H	O
is	O
a	O
true	O
functional	O
Spt3	O
homologue	O
,	O
we	O
tested	O
for	O
complementation	O
of	O
an	O
spt3Delta	O
mutation	O
in	O
yeast	O
.	O

While	O
expression	O
of	O
the	O
full	O
-	O
length	O
SUPT3H	O
is	O
unable	O
to	O
complement	O
an	O
spt3Delta	O
mutation	O
,	O
expression	O
of	O
a	O
human	O
-	O
yeast	O
chimeric	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
that	O
contains	O
42	O
%	O
human	O
sequences	O
can	O
partially	O
complement	O
an	O
spt3Delta	O
mutation	O
.	O

These	O
data	O
suggest	O
that	O
the	O
transcriptional	O
control	O
carried	O
out	O
by	O
Spt3	O
has	O
been	O
conserved	O
from	O
yeast	O
to	O
human	O
.	O

Formation	O
of	O
pluripotent	O
stem	O
cells	O
in	O
the	O
mammalian	O
embryo	O
depends	O
on	O
the	O
POU	O
transcription	O
factor	O
Oct4	O
.	O

Oct4	O
is	O
a	O
mammalian	O
POU	O
transcription	O
factor	O
expressed	O
by	O
early	O
embryo	O
cells	O
and	O
germ	O
cells	O
.	O

We	O
report	O
that	O
the	O
activity	O
of	O
Oct4	O
is	O
essential	O
for	O
the	O
identity	O
of	O
the	O
pluripotential	O
founder	O
cell	O
population	O
in	O
the	O
mammalian	O
embryo	O
.	O

Oct4	O
-	O
deficient	O
embryos	O
develop	O
to	O
the	O
blastocyst	O
stage	O
,	O
but	O
the	O
inner	O
cell	O
mass	O
cells	O
are	O
not	O
pluripotent	O
.	O

Instead	O
,	O
they	O
are	O
restricted	O
to	O
differentiation	O
along	O
the	O
extraembryonic	O
trophoblast	O
lineage	O
.	O

Furthermore	O
,	O
in	O
the	O
absence	O
of	O
a	O
true	O
inner	O
cell	O
mass	O
,	O
trophoblast	O
proliferation	O
is	O
not	O
maintained	O
in	O
Oct4	O
-	O
/	O
-	O
embryos	O
.	O

Expansion	O
of	O
trophoblast	O
precursors	O
is	O
restored	O
,	O
however	O
,	O
by	O
an	O
Oct4	O
target	O
gene	O
product	O
,	O
fibroblast	B-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
.	O

Therefore	O
,	O
Oct4	O
also	O
determines	O
paracrine	B-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
signaling	O
from	O
stem	O
cells	O
to	O
the	O
trophectoderm	O
.	O

Nrf1	B-Gene_or_gene_product
in	O
a	O
complex	O
with	O
fosB	B-Gene_or_gene_product
,	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
jun	I-Gene_or_gene_product
,	O
junD	B-Gene_or_gene_product
and	O
ATF2	B-Gene_or_gene_product
forms	O
the	O
AP1	B-Gene_or_gene_product
component	O
at	O
the	O
TNF	B-Gene_or_gene_product
alpha	I-Gene_or_gene_product
promoter	O
in	O
stimulated	O
mast	O
cells	O
.	O

Cap	O
'	O
n	O
'	O
collar	O
-	O
basic	O
leucine	O
zipper	O
(	O
CNC	O
-	O
bZIP	O
)	O
proteins	O
are	O
widely	O
implicated	O
in	O
developmental	O
processes	O
throughout	O
different	O
species	O
.	O

Evidence	O
is	O
accumulating	O
that	O
some	O
of	O
them	O
are	O
also	O
participating	O
in	O
induced	O
gene	O
expression	O
in	O
the	O
adult	O
.	O

Here	O
we	O
show	O
that	O
the	O
three	O
CNC	O
-	O
bZIP	O
members	O
NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
E2	I-Gene_or_gene_product
,	O
Nrf1	B-Gene_or_gene_product
and	O
Nrf2	B-Gene_or_gene_product
are	O
constitutively	O
expressed	O
in	O
the	O
murine	O
mast	O
cell	O
line	O
CPII	O
and	O
that	O
they	O
form	O
transcription	O
factor	O
complexes	O
with	O
several	O
AP1	B-Gene_or_gene_product
binding	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

Upon	O
induction	O
,	O
complexes	O
are	O
observed	O
at	O
the	O
2	O
x	O
NF	O
-	O
E2	O
consensus	O
binding	O
site	O
and	O
the	O
extended	O
kappa3	O
/	O
AP1	O
(	O
+	O
)	O
site	O
of	O
the	O
TNFalpha	B-Gene_or_gene_product
promoter	O
.	O

The	O
interaction	O
of	O
Nrf1	B-Gene_or_gene_product
with	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
jun	I-Gene_or_gene_product
,	O
junD	B-Gene_or_gene_product
,	O
fosB	B-Gene_or_gene_product
and	O
ATF2	B-Gene_or_gene_product
in	O
mast	O
cells	O
is	O
in	O
contrast	O
to	O
the	O
recently	O
reported	O
binding	O
of	O
Nrf1	B-Gene_or_gene_product
alone	O
at	O
the	O
kappa3	O
/	O
AP1	O
(	O
-	O
)	O
site	O
in	O
dendritic	O
cells	O
.	O

We	O
speculated	O
that	O
this	O
may	O
be	O
the	O
result	O
of	O
the	O
expression	O
of	O
isoforms	O
of	O
Nrf1	B-Gene_or_gene_product
in	O
mast	B-Gene_or_gene_product
cells	I-Gene_or_gene_product
.	O

Using	O
a	O
PCR	O
cloning	O
strategy	O
,	O
we	O
have	O
isolated	O
six	O
novel	O
splice	O
variants	O
of	O
this	O
transcription	O
factor	O
.	O

Some	O
of	O
them	O
have	O
deleted	O
the	O
translational	O
stop	O
codon	O
,	O
resulting	O
in	O
an	O
Nrf1	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
with	O
an	O
altered	O
leucine	O
zipper	O
region	O
.	O

Expression	O
of	O
this	O
altered	O
binding	O
/	O
interaction	O
domain	O
interferes	O
with	O
TNFalpha	B-Gene_or_gene_product
induction	O
,	O
indicating	O
an	O
interaction	O
of	O
this	O
splice	O
variant	O
with	O
the	O
active	O
AP1	O
/	O
NF	O
-	O
AT	O
complex	O
at	O
this	O
promoter	O
.	O

Further	O
complexity	O
of	O
the	O
human	O
SOX	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
family	I-Gene_or_gene_product
revealed	O
by	O
the	O
combined	O
use	O
of	O
highly	O
degenerate	O
primers	O
and	O
nested	O
PCR	O
.	O

SOX	O
proteins	O
contain	O
a	O
conserved	O
HMG	O
-	O
related	O
DNA	O
-	O
binding	O
domain	O
.	O

They	O
fulfill	O
essential	O
functions	O
during	O
the	O
development	O
of	O
animals	O
.	O

Mutations	O
in	O
several	O
SOX	B-Gene_or_gene_product
genes	I-Gene_or_gene_product
have	O
been	O
implicated	O
in	O
human	O
diseases	O
.	O

We	O
present	O
here	O
a	O
new	O
set	O
of	O
PCR	O
primers	O
designed	O
to	O
amplify	O
a	O
broad	O
range	O
of	O
SOX	B-Gene_or_gene_product
HMG	O
-	O
box	O
sequences	O
.	O

These	O
primers	O
facilitated	O
the	O
cloning	O
of	O
several	O
new	O
SOX	B-Gene_or_gene_product
HMG	O
boxes	O
from	O
human	O
genomic	O
DNA	O
,	O
revealing	O
unexpected	O
complexity	O
of	O
the	O
SOX	B-Gene_or_gene_product
gene	I-Gene_or_gene_product
family	I-Gene_or_gene_product
.	O

Requirement	O
of	O
RSF	B-Gene_or_gene_product
and	O
FACT	B-Gene_or_gene_product
for	O
transcription	O
of	O
chromatin	O
templates	O
in	O
vitro	O
.	O

Transcription	O
of	O
naked	O
DNA	O
in	O
vitro	O
requires	O
the	O
general	O
transcription	O
factors	O
and	O
RNA	O
polymerase	O
II	O
.	O

However	O
,	O
this	O
minimal	O
set	O
of	O
factors	O
is	O
not	O
sufficient	O
for	O
transcription	O
when	O
the	O
DNA	O
template	O
is	O
packaged	O
into	O
chromatin	O
.	O

Here	O
,	O
a	O
factor	B-Gene_or_gene_product
that	O
facilitates	O
activator	O
-	O
dependent	O
transcription	O
initiation	O
on	O
chromatin	O
templates	O
was	O
purified	O
.	O

This	B-Gene_or_gene_product
factor	I-Gene_or_gene_product
,	O
remodeling	B-Gene_or_gene_product
and	I-Gene_or_gene_product
spacing	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
RSF	B-Gene_or_gene_product
)	O
,	O
has	O
adenosine	O
triphosphate	O
-	O
dependent	O
nucleosome	O
-	O
remodeling	O
and	O
spacing	O
activities	O
.	O

Polymerases	O
that	O
initiate	O
transcription	O
with	O
RSF	B-Gene_or_gene_product
can	O
only	O
extend	O
their	O
transcripts	O
in	O
the	O
presence	O
of	O
FACT	B-Gene_or_gene_product
(	O
facilitates	B-Gene_or_gene_product
chromatin	I-Gene_or_gene_product
transcription	I-Gene_or_gene_product
)	O
.	O

Thus	O
,	O
the	O
minimal	O
factor	B-Gene_or_gene_product
requirements	O
for	O
activator	O
-	O
dependent	O
transcription	O
on	O
chromatin	O
templates	O
in	O
vitro	O
have	O
been	O
defined	O
.	O

A	O
novel	O
function	O
for	O
SMN	B-Gene_or_gene_product
,	O
the	O
spinal	O
muscular	O
atrophy	O
disease	O
gene	O
product	O
,	O
in	O
pre	O
-	O
mRNA	O
splicing	O
.	O

Spinal	O
muscular	O
atrophy	O
(	O
SMA	O
)	O
is	O
a	O
common	O
motor	O
neuron	O
degenerative	O
disease	O
that	O
results	O
from	O
reduced	O
levels	O
of	O
,	O
or	O
mutations	O
in	O
,	O
the	O
Survival	B-Gene_or_gene_product
of	I-Gene_or_gene_product
Motor	I-Gene_or_gene_product
Neurons	I-Gene_or_gene_product
(	O
SMN	B-Gene_or_gene_product
)	O
protein	O
.	O

SMN	B-Gene_or_gene_product
is	O
found	O
in	O
the	O
cytoplasm	O
and	O
the	O
nucleus	O
where	O
it	O
is	O
concentrated	O
in	O
gems	O
.	O

SMN	B-Gene_or_gene_product
interacts	O
with	O
spliceosomal	O
snRNP	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
and	O
is	O
critical	O
for	O
snRNP	B-Gene_or_gene_product
assembly	O
in	O
the	O
cytoplasm	O
.	O

We	O
show	O
that	O
a	O
dominant	O
-	O
negative	O
mutant	O
SMN	O
(	O
SMNdeltaN27	O
)	O
causes	O
a	O
dramatic	O
reorganization	O
of	O
snRNPs	B-Gene_or_gene_product
in	O
the	O
nucleus	O
.	O

Furthermore	O
,	O
SMNdeltaN27	O
inhibits	O
pre	O
-	O
mRNA	O
splicing	O
in	O
vitro	O
,	O
while	O
wild	B-Gene_or_gene_product
-	I-Gene_or_gene_product
type	I-Gene_or_gene_product
SMN	I-Gene_or_gene_product
stimulates	O
splicing	O
.	O

SMN	O
mutants	O
found	O
in	O
SMA	O
patients	O
cannot	O
stimulate	O
splicing	O
.	O

These	O
findings	O
demonstrate	O
that	O
SMN	B-Gene_or_gene_product
plays	O
a	O
crucial	O
role	O
in	O
the	O
generation	O
of	O
the	O
pre	O
-	O
mRNA	O
splicing	O
machinery	O
and	O
thus	O
in	O
mRNA	O
biogenesis	O
,	O
and	O
they	O
link	O
the	O
function	O
of	O
SMN	B-Gene_or_gene_product
in	O
this	O
pathway	O
to	O
SMA	O
.	O

BNIP3alpha	B-Gene_or_gene_product
:	O
a	O
human	O
homolog	O
of	O
mitochondrial	O
proapoptotic	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
BNIP3	I-Gene_or_gene_product
.	O

Apoptosis	O
is	O
regulated	O
by	O
interaction	O
of	O
viral	O
and	O
cellular	O
BCL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
family	I-Gene_or_gene_product
antiapoptotic	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
with	O
various	O
pro	B-Gene_or_gene_product
-	I-Gene_or_gene_product
apoptotic	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
,	O
several	O
of	O
which	O
are	O
also	O
members	O
of	O
the	O
BCL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
family	I-Gene_or_gene_product
.	O

Cellular	O
protein	B-Gene_or_gene_product
BNIP3	I-Gene_or_gene_product
is	O
a	O
BCL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
family	I-Gene_or_gene_product
proapoptotic	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
that	O
interacts	O
with	O
viral	O
antiapoptosis	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
such	O
as	O
adenoviruses	O
E1B	B-Gene_or_gene_product
-	I-Gene_or_gene_product
19K	I-Gene_or_gene_product
and	O
EBV	B-Gene_or_gene_product
-	I-Gene_or_gene_product
BHRF1	I-Gene_or_gene_product
and	O
cellular	O
antiapoptosis	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
such	O
as	O
BCL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
and	O
BCL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
xL	I-Gene_or_gene_product
.	O

Database	O
searches	O
indicate	O
that	O
the	O
human	O
genome	O
encodes	O
an	O
open	O
reading	O
frame	O
for	O
a	O
protein	B-Gene_or_gene_product
,	O
BNIP3alpha	B-Gene_or_gene_product
,	O
that	O
shares	O
substantial	O
homology	O
with	O
BNIP3	B-Gene_or_gene_product
.	O

The	O
BNIP3alpha	B-Gene_or_gene_product
open	O
reading	O
frame	O
encodes	O
a	O
protein	B-Gene_or_gene_product
of	O
219	O
amino	O
acids	O
that	O
contains	O
a	O
conserved	O
BH3	O
domain	O
and	O
a	O
COOH	O
-	O
terminal	O
trans	O
-	O
membrane	O
domain	O
,	O
characteristic	O
of	O
several	O
BCL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
family	I-Gene_or_gene_product
proapoptotic	I-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

BNIP3alpha	B-Gene_or_gene_product
interacts	O
with	O
viral	O
antiapoptosis	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
E1B	I-Gene_or_gene_product
-	I-Gene_or_gene_product
19K	I-Gene_or_gene_product
and	O
cellular	O
antiapoptosis	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
BCL	I-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
and	O
BCL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
xL	I-Gene_or_gene_product
.	O

Overexpression	O
of	O
BNIP3alpha	B-Gene_or_gene_product
in	O
transfected	O
cells	O
results	O
in	O
apoptosis	O
and	O
suppresses	O
the	O
antiapoptosis	O
activity	O
of	O
E1B	B-Gene_or_gene_product
-	I-Gene_or_gene_product
19K	I-Gene_or_gene_product
and	O
BCL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
xL	I-Gene_or_gene_product
.	O

Like	O
BNIP3	B-Gene_or_gene_product
,	O
BNIP3alpha	B-Gene_or_gene_product
seems	O
to	O
be	O
predominantly	O
localized	O
in	O
mitochondria	O
.	O

These	O
results	O
suggest	O
that	O
BNIP3alpha	B-Gene_or_gene_product
is	O
a	O
structural	O
and	O
functional	O
homologue	O
of	O
BNIP3	B-Gene_or_gene_product
.	O

BNIP3	B-Gene_or_gene_product
and	O
BNIP3alpha	B-Gene_or_gene_product
seem	O
to	O
be	O
the	O
first	O
examples	O
of	O
homologues	O
among	O
the	O
various	O
human	O
proapoptotic	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
.	O

Northern	O
blot	O
analysis	O
reveals	O
that	O
BNIP3alpha	B-Gene_or_gene_product
is	O
expressed	O
ubiquitously	O
in	O
most	O
human	O
tissues	O
.	O

In	O
contrast	O
,	O
BNIP3	B-Gene_or_gene_product
is	O
expressed	O
well	O
in	O
several	O
human	O
tissues	O
and	O
less	O
abundantly	O
in	O
certain	O
tissues	O
such	O
as	O
placenta	O
and	O
lung	O
.	O

These	O
results	O
suggest	O
that	O
although	O
BNIP3	B-Gene_or_gene_product
and	O
BNIP3alpha	B-Gene_or_gene_product
may	O
promote	O
apoptosis	O
simultaneously	O
in	O
most	O
human	O
tissues	O
,	O
BNIP3alpha	B-Gene_or_gene_product
may	O
play	O
a	O
more	O
universal	O
role	O
.	O

Functional	O
association	O
of	O
Nmi	B-Gene_or_gene_product
with	O
Stat5	B-Gene_or_gene_product
and	O
Stat1	B-Gene_or_gene_product
in	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
-	O
and	O
IFNgamma	B-Gene_or_gene_product
-	O
mediated	O
signaling	O
.	O

Using	O
the	O
coiled	O
-	O
coil	O
region	O
of	O
Stat5b	B-Gene_or_gene_product
as	O
the	O
bait	O
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
,	O
we	O
identified	O
the	O
association	O
of	O
Nmi	B-Gene_or_gene_product
,	O
a	O
protein	B-Gene_or_gene_product
of	O
unknown	O
function	O
previously	O
reported	O
as	O
an	O
N	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Myc	I-Gene_or_gene_product
interactor	O
.	O

We	O
further	O
show	O
that	O
Nmi	B-Gene_or_gene_product
interacts	O
with	O
all	O
STATs	B-Gene_or_gene_product
except	O
Stat2	O
.	O

We	O
evaluated	O
two	O
cytokine	B-Gene_or_gene_product
systems	O
,	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
and	O
IFNgamma	B-Gene_or_gene_product
,	O
and	O
demonstrate	O
that	O
Nmi	B-Gene_or_gene_product
augments	O
STAT	B-Gene_or_gene_product
-	O
mediated	O
transcription	O
in	O
response	O
to	O
these	O
cytokines	B-Gene_or_gene_product
.	O

Interestingly	O
,	O
Nmi	B-Gene_or_gene_product
lacks	O
an	O
intrinsic	O
transcriptional	O
activation	O
domain	O
;	O
instead	O
,	O
Nmi	B-Gene_or_gene_product
enhances	O
the	O
association	O
of	O
CBP	O
/	O
p300	O
coactivator	O
proteins	O
with	O
Stat1	B-Gene_or_gene_product
and	O
Stat5	B-Gene_or_gene_product
,	O
and	O
together	O
with	O
CBP	B-Gene_or_gene_product
/	I-Gene_or_gene_product
p300	I-Gene_or_gene_product
can	O
augment	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
-	O
and	O
IFNgamma	B-Gene_or_gene_product
-	O
dependent	O
transcription	O
.	O

Therefore	O
,	O
our	O
data	O
not	O
only	O
reveal	O
that	O
Nmi	B-Gene_or_gene_product
can	O
potentiate	O
STAT	B-Gene_or_gene_product
-	O
dependent	O
transcription	O
,	O
but	O
also	O
suggest	O
that	O
it	O
can	O
augment	O
coactivator	O
protein	O
recruitment	O
to	O
at	O
least	O
some	O
members	O
of	O
a	O
group	O
of	O
sequence	O
-	O
specific	O
transcription	O
factors	O
.	O

